University of Pennsylvania

ScholarlyCommons
Publicly Accessible Penn Dissertations
2015

Innate Immune Response to Coxiella Burnetii
William Paul Bradley
University of Pennsylvania, wbradley@mail.med.upenn.edu

Follow this and additional works at: https://repository.upenn.edu/edissertations
Part of the Allergy and Immunology Commons, Immunology and Infectious Disease Commons,
Medical Immunology Commons, and the Microbiology Commons

Recommended Citation
Bradley, William Paul, "Innate Immune Response to Coxiella Burnetii" (2015). Publicly Accessible Penn
Dissertations. 1620.
https://repository.upenn.edu/edissertations/1620

This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/1620
For more information, please contact repository@pobox.upenn.edu.

Innate Immune Response to Coxiella Burnetii
Abstract
Intracellular bacteria pose a unique set of challenges for the immune system. Many have evolved highly
specialized virulence factors to evade intracellular detection and created a replicative niche. Coxiella
burnetii is a zoonotic intracellular pathogen capable of causing severe acute and chronic Q fever in
humans. C. burnetii grows in the lysosome and persists in cells for more than 10 days. Since C. burnetii
can replicate inside cells for a prolonged period, we hypothesized that C. burnetii evolved multiple
mechanisms to subvert innate immune detection. To test this hypothesis, we tested the ability of the C.
burnetii Nine Mile Phase II clone 4/RSA439 strain to activate innate immune responses in restrictive
C57BL/6 bone marrow-derived macrophages, specifically: detection by surface and cytosolic immune
sensors; activation of the inflammasome; and production of Type I interferon. We found C. burnetii does
not robustly stimulate cytosolic sensors, activate the inflammasome, nor induce robust levels of Type I
interferon. These pathways do not play a significant role in mediating cell-intrinsic control of bacterial
replication. We found TLR detection, specifically TLR2 and TLR4, primarily mediates innate immune
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macrophages. Although expression of GBPs are induced upon C. burnetii infection, we ruled out five GBPs
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manner, and ROS is also induced and plays a role in the cell-intrinsic control of C. burnetii replication.
Together, these studies demonstrate that the C. burnetii Nine Mile phase II strain is able to evade many
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ABSTRACT

THE INNATE IMMUNE RESPONSE TO COXIELLA BURNETII

William P. Bradley
Sunny Shin
Intracellular bacteria pose a unique set of challenges for the immune system. Many have
evolved highly specialized virulence factors to evade intracellular detection and created
a replicative niche. Coxiella burnetii is a zoonotic intracellular pathogen capable of
causing severe acute and chronic Q fever in humans. C. burnetii grows in the lysosome
and persists in cells for more than 10 days. Since C. burnetii can replicate inside cells for
a prolonged period, we hypothesized that C. burnetii evolved multiple mechanisms to
subvert innate immune detection. To test this hypothesis, we tested the ability of the C.
burnetii Nine Mile Phase II clone 4/RSA439 strain to activate innate immune responses
in restrictive C57BL/6 bone marrow-derived macrophages, specifically: detection by
surface and cytosolic immune sensors; activation of the inflammasome; and production
of Type I interferon. We found C. burnetii does not robustly stimulate cytosolic sensors,
activate the inflammasome, nor induce robust levels of Type I interferon. These
pathways do not play a significant role in mediating cell-intrinsic control of bacterial
replication. We found TLR detection, specifically TLR2 and TLR4, primarily mediates
innate immune detection and restriction of C. burnetii in C57BL/6 macrophages. We
further implicated both TLR adaptors MYD88 and TRIF in this response. Building upon
these findings, we demonstrated soluble TNF induced by TLR signaling plays a major
role in the cell-intrinsic restriction of C. burnetii. We further examined TNF-dependent
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mechanisms of restriction: cell death, reactive nitrogen (RNS) and reactive oxygen
(ROS) species, and guanylate binding proteins (GBPs). We found cell death is not
induced in macrophages. Although expression of GBPs are induced upon C. burnetii
infection, we ruled out five GBPs as mediators of bacterial restriction. Finally, we found
RNS is induced by C. burnetii in a TNF-dependent manner, and ROS is also induced
and plays a role in the cell-intrinsic control of C. burnetii replication. Together, these
studies demonstrate that the C. burnetii Nine Mile phase II strain is able to evade many
arms of the innate immune system in C57BL/6 macrophages and implicated a specific
molecule, TNF, in mediating the cell-intrinsic control of this poorly understood bacterium.
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CHAPTER 1:
Introduction: Immune Response to Coxiella burnetii

William P. Bradley

Department of Microbiology, University of Pennsylvania, Philadelphia, PA, 19104, USA
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General Introduction
Successful protection of hosts from pathogenic bacteria, viruses, parasites, and fungi
involves the activation of complex immune networks that are also tightly regulated to
prevent damage to the host. Multicellular organisms have evolved a diverse set of innate
immune responses to prevent infection and establish long-lasting immunity. The
successful clearance of a pathogen is first initiated by a series of sensor molecules that
date back to single organisms and are present in all eukaryotes. These sensors, termed
Pattern Recognition Receptors (PRRs), aid host organisms in distinguishing between
pathogenic and non-pathogenic bacteria, while at the same time limiting the potential of
recognizing self-associated molecules (Janeway and Medzhitov, 2002; Medzhitov, 2007;
Vance et al., 2009). Intracellular bacteria pose a unique set of challenges for the immune
system. Living inside the host cell shields them from recognition by complement,
antibodies, and circulating immune cells. Many of these intracellular bacteria have
evolved strategies to hijack host machinery to both prevent detection and establish a
replicative niche.
Coxiella burnetii, the causative agent of Q (query) fever, is a poorly understood grampositive intracellular bacteria. It is the only known bacteria to inhabit and replicate in the
lysosome, an organelle often thought of to be the dead end of a bacteria’s life cycle
(Voth and Heinzen, 2007). Q fever can cause acute and chronic infections and is
transmitted via an aerosol route with alveolar macrophages as the primary cell target
(Raoult et al., 2005). Remarkably, as few as one bacterium can cause productive
infection (Moos and Hackstadt, 1987). Once internalized by host cells, C. burnetii uses a
specialized secretion system, termed the Type IV secretion system (T4SS), to inject
effector proteins that are thought to target host cell machinery to aid in the maturation
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and expansion of its unique parasitophorous vacuole (PV) (Heinzen et al., 1996;
Seshadri et al., 2003; van Schaik et al., 2013). Inside the cell, C. burnetii is able to
survive and replicate for days and form a vacuole that occupies the majority of the host
cell cytosol (van Schaik et al., 2013). Systemically, C. burnetii does not induce robust
neutrophil recruitment and requires an adaptive immune response for clearance (Elliott
et al., 2013). In some instances, C. burnetii is able to overcome innate and adaptive
immune barriers and establish chronic infection, spreading to the heart and liver to cause
severe pathology in the host organism (Maurin and Raoult, 1999; Raoult et al., 2005).
Despite its relatively early discovery in 1937, little is known about the innate immune
response to C. burnetii (Derrick, 1983; Kovácová and Kazár, 2002). Due to the potential
to cause severe disease in humans, its global presence (Marrie, 2010), and the potential
to be used as a bioterrorism agent (Hackstadt, 1996), better understanding of the host
immune response to C. burnetii and its evasion strategies are of high importance to limit
the health and economic burdens of this disease.

Innate Immune Detection of Pathogens
Surface sensors
In host defense against pathogens, pattern recognition receptors that reside at the cell
surface serve as the first line of detection to distinguish pathogenic and non-pathogenic
bacteria. All eukaryotic organisms possess one or more of these receptors, which sense
a broad array of pathogen-specific molecules. In vertebrate animals, surface and
endosomal Toll-like receptors (TLRs) recognize molecular patterns, many of which are
unique to bacteria, viruses, eukaryotic parasites, and fungi. Mice encode twelve
functional TLRs, while humans encode ten. TLRs 1, 2, 4, 5, 6, 10 are exist on the cell
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surface, while TLRs 3, 7, 8, and 9 are present in endosomes (Akira, 2003). These
receptors use their N-terminal extracellular leucine-rich repeat domains to bind
conserved microbial products, termed Pathogen-Associated Molecular Patterns
(PAMPs) (Janeway and Medzhitov, 2002), or host stress signals, termed DangerAssociated Molecular Patterns (DAMPs). Upon recognition of foreign or host danger
signals, TLRs undergo a conformational change in their C-terminal Toll/interleukin-1
receptor (TIR) domain. This conformational change activates cytosolic adaptor proteins
which in turn activate signaling cascades to initiate anti-microbial responses (Akira,
2003). Monocytes, macrophages, and dendritic cells (DCs) constitutively express all
TLRs while neutrophils, B cells, T cells and epithelial cells express only a few (Kumar et
al., 2009). Each TLR has a distinct repertoire of ligands. The first characterized TLR,
TLR4, was found to recognize lipopolysaccharide (LPS), a component of the gramnegative bacterial cell wall, but has been found to also recognize host heat shock
protein, glycoproteins, and the fusion protein of respiratory syncytial virus (RSV) (Kawai
and Akira, 2009). TLR2 recognizes both gram-negative and gram-positive bacterialassociated lipoproteins, peptidoglycan, and lipoteichoic acid (LTA), TLR2 can also
dimerize with TLR1 or TLR6, providing an extra layer of ligand specificity. TLRs 3, 7, 8,
and 9 all recognize foreign nucleic acids such as double-stranded RNA and DNA. Many
TLR ligands, however, have yet to be discovered and are of great interest in both
infectious and autoimmune diseases (Akira, 2003; Kumar et al., 2009).
All TLRs, except TLR3, signal through the adaptor MyD88, which in turn activates
IRAK4, which then activates the NF-κB pathway and the mitogen-activated protein
kinases (MAPKs) p38 and JNK. Activation of these pathways results in the transcription
and translation of several pro-inflammatory cytokines, including TNF, IL-6, IL-12, and the
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pro-forms of IL-1α and IL-1β. The adaptor Trif is activated by TLR3 and TLR4 and
results in the phosphorylation of interferon regulatory factors (IRFs). IRF3 and IRF7
induce the production of type 1 interferons (IFNs) IFNα and IFNβ. TLR4 can also signal
through Trif to activate the NF-κB pathway and induce pro-inflammatory cytokine
production (Akira, 2003).
The specific TLRs triggered dictate the downstream cell-extrinsic and cell-intrinsic
responses. The ability of surface sensors to detect diverse sets of ligands and induce a
range of signaling cascades provide cells with finely tuned outcomes to a broad range of
pathogenic and host-derived stressors. TLR sensing has been implicated in the
intracellular and systemic restriction of intracellular pathogens M. tuberculosis and L.
pneumophila (Abel et al., 2002; Akamine et al., 2005; Reiling et al., 2002; Spörri et al.,
2006; Zhang et al., 2013).

Cytosolic sensing
In addition to surface sensors, many cell types possess an additional line of defense
in the form of cytosolic sensors. Since many TLR ligands are expressed by both
pathogenic and non-pathogenic or commensal microbes, eukaryotic cells have evolved
strategies to respond to a phenomenon unique to many pathogenic microbes – cytosolic
access.
Most viruses access the cytosol during their natural replication cycle. Some
pathogenic bacteria and parasites access the host cytosol either through the production
of pore-forming toxins, such as Listeriolysin O expressed by the gram-positive bacterium
Listeria monocytogenes (Hamon et al., 2012), or through the use of specialized secretion
systems, such as the Type III secretion systems (T3SS) employed by Salmonella
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enterica and Yersinia spp. and the Type IV secretion systems (T4SS) used by Legionella
pneumophila and Brucella abortis (Cornelis, 2006; de Figueiredo et al., 2015; Pujol and
Bliska, 2005; Qiu and Luo, 2013). These multiprotein structures act as molecular
syringes and inject effector proteins into the host cytosol to hijack host machinery and
establish a replicative niche (Roy and Mocarski, 2007). While cytosolic access is
required for these pathogens to establish infection, host cells have co-evolved innate
immune sensors to respond to this invasion (Franchi et al., 2009; Kawai and Akira,
2009).
Cytosolic sensors respond to a variety of PAMPs. Similar to TLRs, the immunological
outcome depends on the specific ligand and sensor. Cytosolic sensors induce signal
transduction cascades analogous to TLRs to produce pro-inflammatory cytokines and
Type I interferons. Some cytosolic sensors are further capable of inducing formation of a
multiprotein complex termed the inflammasome, which activates the host enzymes
caspase-1 and caspase-11 and induces a form of highly inflammatory cell death termed
pyroptosis (Franchi et al., 2009).
One class of cytosolic sensors, nucleotide-binding oligomerization domain (NOD)-like
receptors (NLRs), contain 16 members that are subdivided into five structural families:
NLRAs contain an acid-activation domain; NLRBs contain a baculovirus inhibitor of
apoptosis domain; NLRCs contain a CARD domain; NLRPs contain a pyrin domain; and
NLRXs contain an unidentified domain. The best characterized NLR family members are
the NLRC receptors, NOD1 and NOD2, and the inflammasome-inducing NLRP receptors
(Franchi et al., 2009; Inohara et al., 2005).
Like TLRs, different cell types express different sets of NLRs. NOD1 is ubiquitously
expressed by macrophages, human mononuclear cells, epithelial cells in the airway and
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intestine, and dendritic cells, (Chamaillard et al., 2003; Inohara et al., 2005). NOD2 is
expressed at higher levels in phagocytic cells and Paneth cells of the small intestine
(Carvalho et al., 2015; Kobayashi et al., 2005). NOD1 and NOD2 both recognize
bacterial peptidoglycan secreted by bacteria via outer membrane vesicles or through
their specialized secretion systems. NOD1 has been implicated in the recognition of
Chlamydophila pneumonia (Shimada et al., 2009), Legionella pneumophila (Berrington
et al., 2010; Frutuoso et al., 2010; Shin et al., 2008), Klebsiella pneumonia (Regueiro et
al., 2011), and Pseudomonas aeruginosa (Travassos et al., 2005), while NOD2
responds to Streptococcus pneumonia (Opitz et al., 2004), L. pneumophila (Berrington
et al., 2010; Frutuoso et al., 2010; Shin et al., 2008), E. coli (Theivanthiran et al., 2012),
C. pneumonia (Shimada et al., 2009), and M. tuberculosis (Ferwerda et al., 2005).
A second set of cytosolic sensors, retinoic-acid-inducible protein 1 (RIG-I)-like sensors
(RLRs) and other nucleic acid sensors, have been established in anti-viral responses,
but have recently been shown to respond to bacterial nucleic acids to induce Type I
interferon production (Kawai and Akira, 2009; Yoneyama and Fujita, 2007). Notable
examples in the context of bacterial infections include: DNA-dependent activator of IFNregulatory factors (DAI), which response to S. pneumonia (Parker et al., 2011); leucinerich repeat (in FLII) interacting protein 1, LRRFIP1, which responds to L. monocytogenes
(Yang et al., 2010); RIG-I, MDA5, and RNA Pol III, which respond to L. pneumophila
(Chiu et al., 2009; Monroe et al., 2009); and the absent in melanoma 2 (AIM2)
inflammasome, which responds to F. tularensis and L. monocytogenes (FernandesAlnemri et al., 2010; Rathinam et al., 2010).
The combined action of surface and cytosolic sensors provides host organisms with a
broad and rapid barrier to many pathogens. Some pathogens, however, have evolved
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strategies to evade one or more of these barriers and as a result, establish productive
infection.

Outcomes of Innate Immune Sensing
The specific outcome of surface and cytosolic detection depends on the pathogen
and its ability to activate these sensors. The consequences of innate immune activation
can be grouped into two categories: cell-extrinsic and cell-intrinsic. Cell-extrinsic
responses rely on cytokine, chemokine, and interferon signaling from the infected cell to
neighboring cells in order to mount a multicellular immune response. Cell-intrinsic
responses can occur via signaling from the sensors themselves or via the action of a
secondary molecule such as pro-inflammatory cytokines.

Cell Extrinsic Immune Responses
Innate Immune Cell Activation and Recruitment
Upon stimulation of surface and cytosolic sensors, signaling cascades are activated to
produce and secrete pro-inflammatory cytokines (e.g. TNF, IL-6, IL-12, IL-1α, and IL-1β),
chemokines, and Type I interferons (Akira, 2003; Kawai and Akira, 2009). Proinflammatory cytokines and chemokines can activate and/or recruit other innate and
adaptive immune cells to the site of infection. Type I interferons activate a set of immune
genes that were classically thought to primarily induce an anti-viral response. Recently,
Type I interferons have been implicated in host responses to bacterial infection, but the
mechanisms underlying how they restrict bacterial replication remain poorly understood
(Coers et al., 2007; Manzanillo et al., 2012; Monroe et al., 2010).
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Activation of Humoral Immunity
B cells provide another arm of the immune response and are activated by cytokines
released by stimulated CD4+ T cells or by TLRs expressed on B cells themselves.
Studies have shown that antibodies (Abs) mediate protection against pathogens through
direct bacticidal activity, complement activation, opsonization, cellular activation via Fc or
complement receptors, and Ab-dependent cytotoxicity. Ab-mediated protection has been
described in host defense against the intracellular bacteria Mycobacterium tuberculosis
(Teitelbaum et al., 1998), L. monocytogenes (Edelson et al., 1999), and Ehrlichia
chaffeensis (Li et al., 2001; Winslow et al., 2000).
In addition to direct immune action, specific Ab isotypes have been shown to modulate
Th1 activation via Fc receptors (FcR). Interaction with these serotypes augments the T
cell response by inducing rapid pathogen uptake, processing, and presentation of
pathogen associated antigens. FcR-mediated antibody interactions were implicated in
the T cell immunity against Chlamydia trachomatis (Moore et al., 2002).

Activation of T cell response
The mounting of a T cell response is also mediated by pro-inflammatory cytokines.
The cytokine IL-12 stimulates a Th1 CD4+ T cell response, which results in the release
of IFNgamma and TNF. These cytokines released by T cells make infected cells more
anti-microbial by increasing production of reactive oxygen (ROS) and reactive nitrogen
(RNS) species inside the infected cell to promote pathogen killing.

Cell-intrinsic immune responses
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Detection of pathogens by surface and cytosolic censors can result in a variety of
cell-intrinsic immune responses to limit intracellular infection. These responses can be
activated by the sensors themselves or through their induction of pro-inflammatory
cytokines.

Cell death
Programmed cell death is one cell intrinsic mechanism to limit bacterial infection. The
death of infected cells eliminates the pathogens intracellular niche and, in some
instances, releases pro-inflammatory molecules to alert neighboring cells. Three classes
of programmed cell death have been described: apoptosis, pyroptosis, and nectroptosis
(Ashida et al., 2011; Fink and Cookson, 2005).
Apoptosis is a non-inflammatory cell death and has two forms: intrinsic apoptosis
results when intracellular stressors disrupt the mitochondria membrane, whereas
extrinsic apoptosis occurs via activation of caspase-8 by death receptors present on the
cell surface. Both of these apoptotic cascades converge on capsase-3 which in turn
activates a series of events resulting in DNA fragmentation, membrane blebbing,
deconstruction of cellular components, and cell death (Elmore, 2007).
Necroptosis, or regulated necrosis, occurs as a back up death when the extrinsic,
capsase-8 apoptotic pathway is blocked. This caspase-independent form of cell death
occurs through the TNF receptor (TNFR) which signals to TNFR-associated death
protein TRADD to activate RIP1 kinase, which recruits RIP3 kinase to form the
necrosome. The formation of the necrosome leads to cell death and the release of cell
components containing danger associated molecular patterns (DAMPs), such as
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heatshock protein, ATP, and mitochondrial DNA, which can stimulate the same set of
PRRs as PAMPs (Pasparakis and Vandenabeele, 2015; Vandenabeele et al., 2010).
Pyroptosis is a pro-inflammatory form of cell death that occurs via the activation of the
inflammasome. Inflammasome activation is a two step process. The first signal occurs
when TLRs and cytosolic sensors upregulate inflammsome machinery and the pro forms
of IL-1α and IL-1β. A second signal, such as flagellin or extracellular ATP, binds certain
cytosolic sensors to activate caspases-1 and -11. Caspase activation then initiates cell
death and release of pro-inflammatory IL-1 family cytokines (Casson and Shin, 2013;
Fontana and Vance, 2011; Franchi et al., 2012).

Reactive oxygen and reactive nitrogen species
Stimulation of surface and cytosolic sensors can also induce the production of reactive
oxygen species (ROS) and reactive nitrogen (RNS) species. ROS is generated by the
NADPH phagocytic oxidase (Phox), while RNS is generated by inducible nitric oxide
synthase (iNOS) (Nathan and Shiloh, 2000). Both complexes are expressed in
mononuclear (monocytes and macrophages) and polymorphonuclear (neutrophils)
phagocytes. Neutrophils express more ROS than macrophages, and macrophages
express more RNS than neutrophils (Nathan and Shiloh, 2000).
ROS is generated upon the formation of a multimeric protein complex that is presynthesized in phagocytes. Two membrane-bound proteins, p22phox and gp91phox,
interact with the cytosolic proteins p40phox, p47phox, and p91phox. Upon activation by
phagocytosis, the cytosolic components translocate to the phagosome and assemble
with flavocytochome b558 to form the functional NADPH oxidase complex (Bylund et al.,
2010). Oxygen radicals are formed via electron transfer, which in turn spontaneously
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generate hydrogen peroxide intermediates. Highly toxic hydroxyl radicals and
hypochlorous acid are then generated via the Fenton reaction or by cellular
myeloperoxidase (MPO) (Imlay and Linn, 1988; Imlay, 2008; Tlili et al., 2011). These
molecules likely target bacterial DNA and can also act as signaling molecules to induce
pro-inflammatory cytokines and cell death.
TNF, IFNγ, and TLR ligands, such as LPS, stimulate the de novo synthesis of iNOS,
which contains an N-terminal oxygenase and a C-terminal reductase (Vila-del Sol et al.,
2007). iNOS forms homodimers and localizes to the phagosome in an actin dependent
manner. It produces nitric oxide radicals from the L-arginine substrate (Albakri and
Stuehr, 1996; Baek et al., 1993; Davis et al., 2007). Nitrogen radicals target a complex
repertoire of bacterial components including bacterial DNA, proteins, and lipids. Bacterial
death likely occurs through the disruption of bacterial respiration components (Nathan
and Shiloh, 2000).
Intracellular pathogens have evolved strategies to evade RNS and ROS toxicity. To
scavenge ROS, some pathogenic bacteria encode superoxide dismutases (SODs),
catalases, and peroxiredoxins (Prxns) (Chelikani et al., 2004; Gort and Imlay, 1998;
Parsonage et al., 2005). Low molecular weight thiols and free or residual methionine are
utilized to scavenge both ROS and RNS (Boschi-Muller et al., 2005; Carmel-Harel and
Storz, 2000).

Autophagy
Autophagy, specifically the subclass termed xenophagy, has been implicated in antibacterial defense. When endosomal trafficking of microbes to terminal lysosomes is
subverted, autophagy provides a back up mechanism to degrade foreign invaders. In
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phagocytes, recognition of PAMPs by both surface and cytosolic sensors to induce a
microbicidal form of autophagy known as xenophagy (Levine et al., 2011).

Guanylate Binding Proteins (GBPs)
Recently a family of IFNγ-inducible GTPases termed guanylate binding proteins
(GBPs) have been implicated in the cell-intrinsic control of intracellular pathogens.
Humans encode seven GBPs (hGBP1-7), while mice encode eleven (mGBP1-11)
(Olszewski et al., 2006; Vestal and Jeyaratnam, 2011). GBPs are classically thought to
be induced by Type I and Type II interferons, but select GBPs have been shown to be
induced by IL-1α, IL-1β, and TNF (Vestal and Jeyaratnam, 2011). Upregulated GBPs
are targeted to cellular membranes by isoprenylation, or the addition of a C-15 farnesyl
or C-20 geranylgeranyl lipid moieties to the cysteine in a conserved C-terminal CaaX
sequence (Vestal and Jeyaratnam, 2011). Both mice and human GBPs have been
implicated in the control of intracellular bacteria. hGBP-1 and hGBP-2 inhibit replication
of Chlamydia spp (Tietzel et al., 2009); mGBP-5 promotes and mGBPs encoded on
chromosome 3 have been implicated in Salmonella Typhimurium and L. pneumophila
induced pyroptosis, respectively (Meunier et al., 2014; Pilla et al., 2014).

Bacterial Subversion of Sensing
To overcome the wide array of innate immune barriers, pathogenic bacteria have
evolved many strategies to evade or subvert innate immune detection in order to
establish infection. These strategies can be grouped into two categories: the alteration or
deletion of PAMPS, and active inhibition of innate immune signaling via secreted
bacterial effectors or toxins (Bhavsar et al., 2007).
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Immune evasion by molecular changes via evolution
Some pathogens have altered their PAMPs to be non-stimulatory or antagonistic.
One such variation occurs in the Lipid A portion of the LPS expressed by gram-negative
bacteria. TLR4 preferentially recognizes hexa-acylated Lipid A with fatty acid side chains
between 12-16 carbons in length (Miller et al., 2005; Roy and Mocarski, 2007). Species
of Legionella and Rhizobium have increased the length of their fatty acid side chains to
>20 carbons and as a result, are less stimulatory to TLR4 (Schromm et al., 2000).
Helocobacter pylori, a human pathogen of the stomach, encodes a tetra-acylated Lipid A
with fatty acid chains ranging from 16-18 carbons, which is not sensed by TLR4 (Moran
et al., 1997).
To avoid detection by flagellin sensors, such as TLR5 and NAIP5, some bacteria
encode variations in their flagellin or downregulate its expression. Several members of
the α- and ε- classes of the phylum Proteobacteria phylum, including H. pylori, encode
mutations in the N-terminus of flagellin, rendering the molecule incapable of activating
TLR5 (Gewirtz et al., 2004). Other bacteria that invade the mucosal epithelium, such as
Salmonella enterica serovar Typhimurium and Campylobacter jejuni, regulate expression
of their flagellin by turning off expression of the stimulatory molecule to successfullly
colonize the host (Kinsella et al., 1997; Simon and Samuel, 2007).
Gram-positive bacteria have also evolved strategies to evade detection. To shield
their cell wall from TLR2 detection, Streptococcus pneumoniae and Klebsiella
pneumoniae form a polysaccharide capsule (Benghezal et al., 2007; Geno et al., 2015;
Regueiro et al., 2011). Distinct structural adaptations in both gram-positive and gram-
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negative bacteria have allowed many species to thwart host recognition and establish
productive infection.

Use of toxins or effector proteins to evade innate immunity
Bacteria also encode virulence factors that target and dampen innate immune
responses. The gram-positive bacterium Baccillus anthracis encodes a metalloprotease
toxin that targets and inactivates MAPKs, resulting in apoptosis of macrophages and
dendritic cells. The induction of apoptosis is thought to prevent signaling from these
immune cells to other cells, allowing B. anthracis to colonize the host (Collier and Young,
2003).
Some species of gram-negative bacteria encode specialized secretion systems, such
as the Type III and Type IV secretion systems. These multi-protein complexes act as
molecular syringes that are thought to form pores in cell surface or endosomal
membranes and translocate effector proteins that target host machinery (Diepold and
Armitage, 2015; Trokter et al., 2014). Many of these effector proteins have eukaryoticlike domains – likely the result of horizontal gene transfer. Effector proteins target
numerous host processes, including various signaling cascades, vesicular transport,
gene expression, and cell death pathways . Type III secretion systems are encoded by
many bacteria, including Yersinia spp. and Salmonella spp, and Type IV secretion
systems are encoded by several other bacteria, including Legionella spp., Brucella
abortis, and C. burnetii (Diepold and Armitage, 2015; Trokter et al., 2014).

Coxiella burnetii
Epidemiology
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Coxiella burnetii is a gram-negative, intracellular bacterium that causes Q (query) fever
in humans. Q fever can manifest as an acute infection with flu-like symptoms or progress
to a system chronic infection which can lead to endocarditis or hepatitis (Maurin and
Raoult, 1999; Raoult et al., 2005). Livestock is the primary reservoir for C. burnetii, with
many outbreaks linked to goats (Raoult et al., 2005; Whelan et al., 2011). The bacteria
can persist in herds and spread in massive quantities during the livestock birthing
process, and infection of pregnant livestock often results in stillbirths (Di Domenico et al.,
2014; Raoult et al., 2005). Transmission leads to persistence within herds and puts
nearby humans at a high risk of exposure. While human-to-human transmission is
extremely rare, a recent three year outbreak in the Netherlands linked to dairy goat
farms that resulted in over 4,000 human cases and mass culling of goat herds
highlighted the potential health and economic burden C. burnetii can cause (Enserink,
2010; Roest et al., 2011). The only C. burnetii vaccine approved for human use is
available solely in Australia. While proven effective at protecting non-exposed
individuals, it can also cause severe adverse reactions in individuals previously exposed
to C. burnetii (Chiu and Durrheim, 2007). The outbreak potential, limited prophylaxis
options, and potential use as a bioterrorism agent highlight the need for a better
understanding of C. burnetii pathogenesis and how the host immune response can
successfully control this organism.
Despite the relatively early discovery of C. burnetii in 1937, knowledge of other
bacterial pathogens have far outpaced C. burnetii due to its BSL-3 and Select Agent
designation and history as an obligate intracellular pathogen, with past difficulties with
cell-free growth (Derrick, 1983; Raoult et al., 2005). The generation of an avirulent BSL-2
lab strain and the recent development of axenic media has opened doors for a better
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molecular understanding of C. burnetii’s pathogenesis (Omsland et al., 2009;
Vishwanath and Hackstadt, 1988).
The primary entry route for C. burnetii in humans is through inhalation into the lung
and infection of alveolar macrophages (Raoult et al., 2005; van Schaik et al., 2013).
While it is known that C. burnetii can infect any nucleated cell, it is thought to prefer
macrophages (Elliott et al., 2013). The incubation time prior to the onset of disease
symptoms varies from a few days to months, a relatively long period compared to other
pathogens (Raoult et al., 2005). Acute infection occurs in ~40% of exposed individuals,
where patients experience flu-like symptoms that can last for days to weeks (Harris et
al., 2000). Cases of acute infection are largely self-limiting and can be treated with a two
week regiment of doxycycline (Raoult et al., 2005). 1-5% of acute presentations can
progress to a more severe chronic infection which can have devastating consequences
(Tissot-Dupont and Raoult, 2008). In chronically infected individuals, C. burnetii spreads
to the heart and liver and can cause severe endocharditis or hepatitis, with patients often
needing heart valve replacement surgery or liver transplants (Tissot-Dupont and Raoult,
2008).

Coxiella burnetii biology
C. burnetii is a gram-negative intracellular bacteria of the phylum Proteobacteria,
class γ-Proteobacteria, order Legionalles, class Coxiellaceae (Maurin and Raoult, 1999;
Roux et al., 1997; Stein et al., 1993). C. burnetii’s genome contains ~2.0-2.2 Mb with
~57.8% AT’s, which is thought to aid in homologous gene transfer of eukaryotic-like
proteins that aid in its pathogenesis (Raghavan et al., 2008; Seshadri et al., 2003). It is a
relatively small bacteria with its size ranging from 0.2-0.4 μM wide and 0.4-1 μM long,
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and it is highly resistant to environmental stressors such as dessication and heat (Raoult
et al., 2005). Its replication time is estimated at 12-20 hours (Zamboni et al., 2002).
C. burnetii has a pleomorphic coccobacilli shape and exists as two morphologically
distinct cell types. The environmentally stable, non-replicative, small cell variant (SCV) is
characterized by condensed chromatin and is thought to be the more infectious of the
two variants (Hackstadt and Williams, 1981). The replicative, large cell variant (LCV)
develops upon internalization by the host cell or when introduced into nutrient-rich,
acidified citrate cysteine medium (ACCM) (Coleman et al., 2004; Hackstadt and
Williams, 1981; Omsland et al., 2013). This morphological shift is marked by alterations
in the surface protein composition, activation of metabolism pathways, and replication
(Coleman et al., 2004; 2007). Once the bacteria reaches stationary phase either inside
the host cell or in axenic media, the bacteria revert back to the small cell variant
(Coleman et al., 2004; 2007; Omsland et al., 2013).
Further variations occur with the bacterium’s lipopolysaccharide. The smooth, virulent
form (Phase I) contains a highly branched O-chain, containing the unusual sugars
virenose (6-deoxy-3-C-methyl-D-gulose) and dihydrohydroxystreptose (3-C(hydroxymethyl)-L-lyxose (Amano et al., 1987; Moos and Hackstadt, 1987; Toman and
Kazár, 1991). This branching is thought to aid in the evasion of serum-mediated killing
(Vishwanath and Hackstadt, 1988). The attenuated and laboratory adapted Nine Mile
Phase II clone 4/RSA439 strain is the standard lab strain, and was derived from the
virulent Nine Mile phase I strain via serial lab passages in embryonated eggs. Serial
passage resulted in the deletion of large chromosomal regions containing open reading
frames associated with O-chain synthesis, which is thought to account for its attenuated
virulence in vivo (Moos and Hackstadt, 1987).
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Coxiella burnetii inside the host cell
C. burnetii is internalized by two mechanisms: active phagocytosis and passive
binding to leukocyte response integrin (αVβ3 integrin) and CR3 receptor (Boyle and
Finlay, 2003; Capo et al., 1999; Dellacasagrande et al., 2000). Once internalized, C.
burnetii traffics down the canonical endosomal pathway, terminating in an acidic,
lysosome-like compartment (Heinzen et al., 1996; Kinchen and Ravichandran, 2008).
The C. burnetii-containing vacuole also engages autophagy pathways, and can undergo
homotypic fusion with other C. burnetii-containing vacuoles (Heinzen et al., 1996;
Romano et al., 2007). Authophagic engagement is thought to provide the bacteria with
nutrients and membrane for vacuole expansion (Romano et al., 2007). Unlike Legionella,
which blocks lysosomal maturation of its vacuole (Isberg et al., 2008), C. burnetii traffics
to a fully mature phagolysosome containing both early endosomal marker Rab5 and late
endosomal marker Rab7 (Berón et al., 2002). The mature PV also contains the
lysosome-associated marker LAMP-1, the lysosomal hydrolase acid phosphatase, and
cathepsin D (Heinzen et al., 1996; Howe et al., 2010). Upon lysosomal maturation, C.
burnetii begins to form its intracellular niche, the parasitophorous vacuole, which takes
~24-48 hours to mature (Heinzen et al., 1996; Howe et al., 2003). Approximately 8 hours
post internalization, C. burnetii undergoes a morphological switch from the infective
small cell variant to replicative large cell variant and begins injecting effector proteins into
the host cell via its Type IV secretion system (Newton et al., 2013). These effectors are
thought to hijack host cell machinery to enable the acquisition of nutrients and host
membrane, and prevent host cell death (Coleman et al., 2004; Heinzen et al., 1996; van
Schaik et al., 2013). C. burnetii continues to replicate in this PV for days, forming a large
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vacuole that can occupy the majority of the host cell cytosol and can contain upwards of
100 bacteria per vacuole (Coleman et al., 2004).

Coxiella burnetii’s Type IV Secretion System
C. burnetii encodes a Type IV secretion system (T4SS) that delivers bacterial effector
proteins to the host cytosol (van Schaik et al., 2013). C. burnetii’s T4SS is highly
homologous to L. pneumophila’s Dot/Icm (defect in organelle trafficking/intracellular
multiplication) T4SS system (Seshadri et al., 2003). Previous studies that identified many
of the known C. burnetii T4SS effector proteins utilized L. pneumophila as a surrogate
for translocation assays to screen or test potential C. burnetii effectors, as its T4SS is
both genetically and functionally homologous to L. pneumophila’s T4SS (Vogel, 2004;
Zamboni et al., 2003). To date, over 100 effector proteins have been identified. Many of
these effectors have eukaryotic domains and are targeted to distinct regions of the cell
(van Schaik et al., 2013). Since a functional T4SS is necessary for bacterial replication
(Beare et al., 2011), it is thought that these effector proteins hijack host machinery to aid
in vacuole formation, nutrient acquisition, alteration of gene expression, and subversion
of host immune responses. So far, three effectors, AnkG, CaeA, and CaeB, have been
linked to the inhibition of intrinsic apoptosis (Klingenbeck et al., 2013; Lührmann et al.,
2010), and several effectors have been linked to vacuole formation (Graham et al., 2015;
Larson et al., 2013; 2015; Newton et al., 2014; Weber et al., 2013).

Host recognition of Coxiella burnetii
Unlike L. pneumophila, which evolved to infect single cell amoeba and has not
acquired virulence factors that specifically interfere with innate or adaptive immunity,
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successful clearance of C. burnetii requires both innate and adaptive immune
responses. The activation of innate immune pathways and the downstream adaptive
response remain poorly understood.

TLR and NLR Sensing
Studies on innate immune recognition of C. burnetii have shown differing results
depending on the bacterial strain or host cell used and have largely focused on TLR2
and TLR4. One study showed that Phase I C. burnetii productively replicates in human
dendritic cells without stimulating TLR2 or the maturation of the DCs (Shannon et al.,
2005). Another study demonstrated that C. burnetii Phase II does stimulate TLR2,
resulting in the secretion of TNF (Zamboni, 2004). In this study, TLR2 was found to play
a role in inhibiting growth in C57BL/6-background murine bone marrow-derived
macrophages as Tlr2-/- macrophages showed increased vacuole size and bacterial
replication (Zamboni et al., 2003). A recent study further demonstrated that TLR2
signaling relied on heterodimerization with TLR1, while TLR6 deficiency did not result in
an attenuated immune response in response to infection with the Nine Mile strain
(Ammerdorffer et al., 2014). It is hypothesized that the highly branched Phase I LPS acts
as a shield and prevents exposure of TLR2 agonists, which could explain the previously
described robust Th1 response in mice infected with Phase II, but not Phase I bacteria
(Roy and Mocarski, 2007; Schromm et al., 2000).
The role of TLR4 is still unclear. It was found that TLR4 mediates bacterial uptake of
Phase I, but not Phase II bacteria (Honstettre et al., 2004). Furthermore, the previous
study linking TLR2 detection of C. burnetii to production of TNF in mouse macrophages
demonstrated purified C. burnetii lipid A was a TLR4 antagonist (Zamboni et al., 2004).
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The same study implicating TLR1-mediated detection of C. burnetii also showed that
NOD2 plays a role in cytokine production, providing insight into the first potential
cytosolic sensor activated by C. burnetii (Ammerdorffer et al., 2014).

Neutrophil Recruitment
Neutrophil recruitment to the site of infection is a major defense mechanism against a
variety of lung pathogens, usually occurring around 24 to 48 hours post-infection
(Balamayooran et al., 2010). It was shown that C. burnetii delays neutrophil recruitment
for approximately seven days (Elliott et al., 2013). The same research group further
performed a study indicating that neutrophils are important for clearance, as antibodymediated depletion of neutrophils resulted in more severe infection (Elliott et al., 2013).
The recruitment of neutrophils during C. burnetii infection was found to be independent
of both CXCL2 and IL-17, two classical neutrophil recruitment molecules (Balamayooran
et al., 2010; Elliott et al., 2015).

Adaptive Immune Response
Successful clearance of C. burnetii requires an adequate adaptive immune
response. Studies in SCID and nude mice, which lack both T and B cells, are highly
susceptible to C. burnetii infection (Andoh et al., 2003; Kishimoto et al., 1978).
Furthermore, immunocompromised individuals, such as patients on immunosuppressive
treatment, with lymphomas, or pregnant individuals are more likely to develop chronic Q
fever (Capo and Mege, 2012).
Successful control of acute Q fever relies on a systemic T cell response, likely Th1,
and granuloma formation (Maurin and Raoult, 1999). SCID mice reconstituted with CD4+
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T cells or CD8+ T cells are able to control infection (Read et al., 2010). The T cell
response is thought to rely heavily on the production of IFNγ, as IFNγ-deficient mice
exhibit high mortality (Andoh et al., 2007). The exact microbicidal programs that IFNγ
stimulates to control C. burnetii infection remain unclear. T cells are also involved in the
formation of granulomas, which are thought to be necessary for clearance during acute
phase because patients with chronic Q fever have fewer granulomas (Koster et al.,
1985a; 1985b).
It is known that both infection with C. burnetii and injection of C. burnetii antigens into
mice induces a significant antibody response in animals and humans (Behymer et al.,
1975; Guigno et al., 1992; Kishimoto and Burger, 1977; Peacock et al., 1979). Patients
with acute Q fever have been shown to develop IgM specific antibodies to Phase I
antigen and IgM, IgG, and IgA antibodies to Phase II antigen, whereas patients with
chronic Q fever did not produce detectable levels of IgM, but had high levels of both IgA
and IgG (Worswick and Marmion, 1985). Mixtures of virulent C. burnetii and antibody
were found to be noninfectious when injected into animals, and studies with formalinkilled C. burnetii vaccines in humans directly linked antibodies to the control of C.
burnetii infection (Lackman et al., 1962; Ormsbee et al., 1964; Peacock et al., 1979).
Administered C. burnetii antibodies were unable, however, to control infection in T celldeficient animals, indicating that T cells are necessary for antibody-mediated clearance
(Andoh et al., 2007; Humphres and Hinrichs, 1981). It is currently hypothesized that a
successful humoral immune response is necessary to control infection, while a
successful T cell response is necessary to completely clear C. burnetii from the host.
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Conclusions
Host cells have evolved a variety of mechanisms to recognize and control intracellular
pathogens. All of these responses rely on the initial detection of the pathogen by innate
immune sensors that reside at the cell surface or within the host cell cytosol. Coxiella
burnetii is a poorly understood pathogen that has the potential to cause severe disease
in humans. While many studies have been done to dissect role individual components
play in the innate and adaptive control of C. burnetii, different findings have been arrived
at using cells from different animal origins, immortalized, and primary cells. Here we
sought to survey the innate immune response mounted by macrophages against the
Nine Mile Phase II clone 4/RSA439 strain in a well-established system employed in the
study of many pathogens, macrophages derived from C57BL/6 mice. Since wild-type
C57BL/6 macrophages are restrictive to C. burnetii growth, we were able to use
C57BL/6 background mice genetically deficient in key components of the host surface
and cytosolic surveillance system to examine C. burnetii’s ability to activate canonical
arms of the innate immune response and decipher the mechanisms underlying cellintrinsic control of C. burnetii within C57BL/6 macrophages.
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Dissertation Aims
Intracellular bacteria pose unique challenges to the host immune response. They have
evolved to live and thrive in specialized intracellular niches, shielded from circulating
immune challenges in the extracellular space such as antibodies and compliment.
Despite the presence of a diverse set of innate immune sensors on the host cell surface
and in the cytosol that can detect microbial pathogens and activate a wide array of
immune responses, pathogens have evolved strategies to subvert this detection and
establish infection.
One intracellular bacterium, Coxiella burnetii, is a poorly understood pathogen
capable of causing severe acute and chronic infection in humans. It is the only known
bacterium to live and replicate in the harsh environment of the lysosome. It also is able
to survive inside cells over a long period of time and delays recruitment of neutrophils by
several days. We hypothesize that C. burnetii has evolved strategies to evade or
delay activation of innate immune pathways in macrophages by either failing to
activate these pathways or blocking activation through the use of its specialized
Type IV secretion system (T4SS). While cells from many organisms are consusive to
productive C. burnetii infection, macrophages from C57BL/6 (B6) mice are able to
control C. burnetii replication via an unknown mechanism. We, therefore, further
hypothesize that despite a lack of robust innate immune activation, C. burnetii
activates a cell-intrinsic innate immune pathway in B6 macrophages. To address
these overarching hypotheses, we pursued the following specific aims:

Aim 1: Determine which innate immune pathways are activated in mouse
macrophages following in vitro infection with C. burnetii. In the first aim, we
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investigated the ability of the C. burnetii Nine Mile Phase II clone 4/RSA439 strain to
activate various components of the innate immune system in C57BL/6 bone marrowderived macrophages. We specifically looked at: the role of surface TLRs and cytosolic
sensors in production of proinflammatory cytokines, TNF and IL-6; the activation of the
inflammasome; and the induction of Type I interferons. C57BL/6 naturally restrict C.
burnetii so we further wanted to determine if these pathways play a role in cell intrinsic
restriction. To expand upon our hypothesis that C. burnetii evolved strategies to evade
innate immune detection, we further tested the role of its type IV secretion system in the
activation of the innate immune response

Aim 2: Determine the mechanism(s) by which TLR-mediated production of TNF
restricts C. burnetii replication within macrophages. We uncovered TNF as a major
player in mediating cell-intrinsic restriction of C. burnetii. Since TNF induces a wide array
of cell-intrinsic immune pathways, we hypothesized that at least one of these pathways
acts to restrict C. burnetii growth. To test this hypothesis, we focused on three possible
TNF-mediated restriction mechanisms: activation of cell death via apoptosis and
necroptosis; the production of reactive nitrogen (RNS) and reactive oxygen (ROS)
species; and the induction of guanylate binding proteins (GBPs). With each of these
pathways, we determined if C. burnetii activated these pathways in C57BL/6
macrophages and then sought to determine if their activation was dependent on TNF
and if they played a role in cell-intrinsic restriction of C. burnetii.
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Together, these aims provide new insight into our understanding of the innate immune
response to C. burnetii in macrophages (Aim 1) and implicated a specific host immune
pathway in directing cell-mediated control of C. burnetii replication (Aim 2).
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Figure 1.1 The intracellular lifestyle of C. burnetii.
C. burnetii is internalized by active phagocytosis or passive binding to leukocyte
response integrin (αVβ3 integrin) and CR3 receptor. Internalized C. burnetii traffics down
the canonical endosomal pathway, terminating in an acidic, lysosome-like compartment
containing Rab5, Rab7, and LAMP-1. 8 hours post internalization, C. burnetii injects
effector proteins into the host cell cytosol to form its replicative niche, the Coxiella
containing vacuole (CCV). 24 hours post infection C. burnetii undergoes a morphological
shift from the infective, metabolically inactive small cell variant (SCV) to the replicative
large cell variant (LCV). Once the CCV is fully formed, the bacteria replicate inside the
lysosome-like vacuole at doubling time of ~12 hours. This replication period persists for
~10 days, with the CCV occupying the majority of the host cell cytosol. At stationary
phase, C. burnetii reverts back to its infective SSV and exits the cell via an unknown
mechanism.
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Abstract
Detection of intracellular bacterial pathogens by extracellular and cytosolic pattern
recognition receptors is a critical first step in mediating cell-intrinsic restriction of
bacterial replication. The intracellular pathogen Coxiella burnetii replicates within
permissive cell types by using a Dot/Icm type IV secretion system (T4SS) to translocate
bacterial effectors into the host cell cytosol. C57BL/6 (B6) mouse macrophages do not
permit replication of the C. burnetii Nine Mile phase II (NMII) strain. However, eliminating
TLR2 allows C. burnetii NMII to replicate within B6 macrophages, implying that innate
immune pathways enable B6 macrophages to restrict C. burnetii replication. Whether
other TLR signaling components or cytosolic immune pathways also sense and restrict
C. burnetii NMII replication in mouse macrophages remains poorly understood. Here, we
found that the TLR signaling adaptors MyD88 and Trif are required for cytokine
production and act in concert to restrict C. burnetii NMII replication. Although we found
that both TLR2 and TLR4 contribute to proinflammatory cytokine responses to C. burnetii
NMII, TLR4 is dispensable for control of NMII replication. In addition, we did not observe
a role for cytosolic sensing of C. burnetii T4SS activity in inflammasome activation or
production of proinflammatory cytokines and type I interferons, nor did these pathways
restrict C. burnetii NMII replication.

Introduction
To initiate innate immune defense and cell-intrinsic control of intracellular bacterial
pathogens, host cells utilize pattern recognition receptors (PRRs) to detect pathogenassociated molecular patterns (PAMPs) (Janeway, 1989; Janeway and Medzhitov, 2002;
Medzhitov, 2007). Toll-like receptors (TLRs) located at the cell surface and within
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endosomes

detect

extracellular

PAMPs

such

as

bacterial

lipoproteins

and

lipopolysaccharide (LPS) (Akira, 2003). Downstream of TLRs, the adaptor molecules
MyD88 and Trif activate several signaling pathways, including nuclear factor-kappa B
(NF-κB), mitogen-activated protein kinases (MAPKs), and interferon regulatory factor 3
(IRF3), which induce expression of proinflammatory cytokines and other anti-microbial
effectors important for bacterial clearance (Akira, 2003). Cytosolic PRRs, such as those
of the Nucleotide Binding Domain/Leucine Rich Repeat (NLR) and RIG-I-like receptor
(RLR) families, respond to PAMPs introduced into the host cell cytosol by pore-forming
toxins or specialized secretion systems of intracellular bacterial pathogens (Fritz et al.,
2006; Inohara et al., 2005; Ting et al., 2006). Many cytosolic PRRs synergize with TLR
signaling for increased proinflammatory cytokine production (Fritz et al., 2006; OviedoBoyso et al., 2014). In addition, a subset of cytosolic PRRs initiate assembly of a
multiprotein complex termed the inflammasome, which activates the host proteases
caspase-1 and caspase-11 (Martinon et al., 2002; Miao et al., 2010; Rathinam et al.,
2012). Active caspase-1 initiates a form of cell death known as pyroptosis, a form of cell
death that can restrict intracellular bacterial infection (Miao et al., 2010; Moltke et al.,
2013; Rathinam et al., 2012). Pyroptosis is accompanied by release of IL-1 family
cytokines (Miao et al., 2010; Moltke et al., 2013; Rathinam et al., 2012). Active caspase11 also induces pyroptosis and IL-1 release (Broz et al., 2012; Gurung et al., 2012;
Kayagaki et al., 2011; Rathinam et al., 2012). Together, these innate immune pathways
collaborate to restrict many intracellular bacterial pathogens through cell-intrinsic and
extrinsic mechanisms.
Coxiella burnetii is a facultative intracellular, gram-negative bacterium responsible for
the zoonotic disease Q (query) fever, an acute flu-like illness that can progress to a
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severe, chronic disease that often manifests as severe endocarditis (Maurin and Raoult,
1999). C. burnetii exists as two phase variants. Virulent phase I C. burnetii synthesizes
LPS with a highly branched O-chain, which shields the bacteria from complementmediated killing in serum and prevents binding of antibodies to cell surface (Hackstadt,
1988; Vishwanath and Hackstadt, 1988). In contrast, lab-adapted avirulent phase II C.
burnetii produce a truncated O-antigen polysaccharide and are trafficked to fully mature
lysosomes in B6 macrophages (Amano et al., 1987; Howe et al., 2010; Moos and
Hackstadt, 1987). A cloned phase II variant of the C. burnetii Nine Mile reference strain
(NMII; RSA493 clone 4) contains a ~26-kb chromosomal deletion that eliminates several
genes involved in LPS biosynthesis and is avirulent in immunocompetent mice and
guinea pigs (Hoover et al., 2002; Moos and Hackstadt, 1987). NMII is a biosafety level 2
organism, whereas all other C. burnetii strains require biosafety level 3. Although the
NMII strain is unable to establish systemic infection in animals, the NMII strain and the
isogenic phase I strain (NMI) are indistinguishable in their ability to replicate in human
and mouse macrophage cell lines and primary human macrophages in vitro (Baca et al.,
1981; Graham et al., 2013; Howe et al., 2010) . There is no difference in the ability of
NMI and NMII to elicit the proinflammatory cytokines TNF and IL-6 from human
macrophages, but there are differences in the induction of other cytokines such as IL-1β,
suggesting that macrophages mount both overlapping and distinct immune responses to
NMI and NMII during in vitro infection (Graham et al., 2013; Howe et al., 2010).
Once inside host cells, the C. burnetii-containing vacuole is directed down the
canonical endosomal pathway, while also engaging the autophagy and early secretory
pathways to form a lysosome-derived vacuole. (Heinzen et al., 1996; Romano et al.,
2007) Within this compartment, C. burnetii is able to resist the bactericidal activities of
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the lysosome and replicate for several days (Coleman et al., 2004; Heinzen et al., 1996).
To establish this unique intracellular niche, C. burnetii utilizes a Dot/Icm type IVB
secretion system to translocate over 100 effector proteins into the host cytosol (Beare et
al., 2011; Carey et al., 2011; Chen et al., 2010; Graham et al., 2015; Lifshitz et al., 2013;
Pan et al., 2008; Voth et al., 2011; 2009). These effector proteins are predicted to target
and manipulate host cell factors, with several effectors established as having roles in
intracellular membrane trafficking and inhibition of host cell apoptosis (Graham et al.,
2015; Klingenbeck et al., 2013; Lührmann and Roy, 2007; van Schaik et al., 2013).
The evolutionarily related pathogen Legionella pneumophila, which causes the severe
pneumonia Legionnaires’ disease, primarily associates with freshwater amoebae (Fields,
1996). Because L. pneumophila has evolved to infect protozoa, it is thought that L.
pneumophila has not evolved evasion strategies to purposely subvert mammalian innate
immune pathways and thus has been a useful model for uncovering innate immune
pathways used by macrophages to restrict intracellular bacterial infection (Shin and Roy,
2008). In support of this, whereas A/J macrophages are permissive for L. pneumophila
replication, C57BL/6 macrophages restrict L. pneumophila replication (Yoshida et al.,
1991). Studying how C57BL/6 macrophages control L. pneumophila replication has
allowed for the identification of TLR-dependent and cytosolic PRR-dependent immune
pathways that collaborate to restrict L. pneumophila replication, such as the
proinflammatory cytokines TNF and type I IFNs and inflammasome-dependent pyroptotic
cell death. Importantly, activation of the inflammasome and other cytosolic immune
pathways requires a functional L. pneumophila Dot/Icm T4SS that translocates bacterial
products, such as flagellin, into the host cell cytosol.
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Primary mouse macrophages of the C57BL/6 genetic background, in contrast to other
inbred backgrounds, are not permissive for C. burnetii NMII infection (Zamboni, 2004;
Zamboni et al., 2002). In contrast to L. pneumophila, how B6 mouse macrophages
detect C. burnetii NMII and restrict intracellular replication of NMII remains poorly
understood. TLR2 plays a major role in the production of proinflammatory cytokines and
elimination of TLR2 signaling renders C57BL/6 macrophages more permissive for
intracellular C. burnetii NMII replication (Zamboni et al., 2004). This indicates that innate
immune sensing plays a critical role in restricting NMII replication in C57BL/6
macrophages. Furthermore, these findings suggest that C57BL/6 macrophages are a
useful model for uncovering cell-intrinsic immune mechanisms that control intracellular
C. burnetii NMII replication.
In contrast to TLR2, TLR4 is thought to be dispensable for immune responses against
C. burnetii, as C. burnetii lipid A is a TLR4 antagonist (Shannon et al., 2005; Zamboni et
al., 2004). Whether other TLRs might work in concert with TLR2 to detect and control C.
burnetii NMII infection is unknown. Similarly, the roles of the TLR signaling adaptors
MyD88 and Trif in mediating macrophage sensing and control of C. burnetii NMII is also
unknown. Since C. burnetii encodes a Dot/Icm T4SS that translocates bacterial products
into the host cell cytosol, it would be predicted that intracellular PRRs are activated that
would restrict NMII replication (Beare et al., 2009; Newton et al., 2013; Segal et al.,
2005; van Schaik et al., 2013). C. burnetii NMII is capable of translocating T4SS
effectors into C57BL/6 macrophages, indicating that the block in bacterial replication
may occur at a step following T4SS effector translocation (Newton et al., 2013). Indeed,
the cytosolic sensor NOD2 was shown to contribute to cytokine production during
infection with C. burnetii phase I organisms, demonstrating the potential for C. burnetii to
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be detected by cytosolic surveillance pathways (Ammerdorffer et al., 2014; Benoit et al.,
2009). Whether cytosolic immune pathways detect and restrict C. burnetii NMII infection
in B6 macrophages is not known.
Here, we set out to identify whether additional TLR or cytosolic immune signaling
pathways are used by C57BL/6 mouse macrophages to detect and restrict C. burnetii
NMII during in vitro infection. In addition to the established role for TLR2 in responding to
NMII and mediating proinflammatory cytokine production, we find that TLR2 and TLR4
work in concert to mediate cytokine responses to NMII, but we observe that TLR4 does
not significantly contribute to the control of NMII replication. Furthermore, the TLR
signaling adaptors MyD88 and Trif are both required for cytokine responses to NMII and
restricting intracellular bacterial replication. Despite the ability of the C. burnetii NMII
T4SS to translocate bacterial products into the cytosol of B6 macrophages, we did not
observe inflammasome activation or an increase in pro-inflammatory cytokine production
in response to C. burnetii NMII compared to isogenic mutants lacking a functional T4SS.
In addition, the key inflammasome caspases, caspase-1 and caspase-11, were
dispensable for control of intracellular NMII replication within B6 macrophages. We also
did not detect robust induction of type I interferons by NMII, nor did we see a role for
type I IFNs in restricting intracellular replication.

Materials and Methods
Ethics statement
All experiments performed in this study involving mice, solely used as a tissue source,
were done so in accordance with the Animal Welfare Act (AWA) and the
recommendations in the Guide for the Care and Use of Laboratory Animals of the
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National Institutes of Health. The Institutional Animal Care and Use Committee of the
University of Pennsylvania approved all procedures (protocols #803465, #803459,
#804714, and #804928).

Bacteria Strains
Coxiella burnetii Nine Mile Phase II (clone 4; RSA 439) and Legionella pneumophila
serogroup 1 background strains were used in all experiments (Berger and Isberg, 1993).
For C. burnetii infections, acidified citrate cysteine medium (ACCM-2) was inoculated
with WT C. burnetii (Omsland et al., 2013), WT C. burnetii expressing mCherry (Beare et
al., 2009), icmL::Tn strain (Carey et al., 2011), which contains a transposon insertion in
the icmL gene rendering the T4SS non-functional, and WT and icmL::Tn strains
harboring a plasmids encoding BlaM alone and BlaM fused to known T4SS substrate
CBU_0077 under control of the CBU_1169 promoter (Carey et al., 2011; Newton et al.,
2013). C. burnetii was grown at 37°C in 5% CO2 and 2.5% O2 for 6 days to late log
phase (~1.0x109 bacteria/mL). One day after inoculation, kanamycin (275 μg/mL) was
added to icmL::Tn cultures and chloramphenicol (3 μg/mL) was added to strains
harboring plasmids encoding BlaM and BlaM-0077 fusion proteins (Carey et al., 2011).
To quantify C. burnetii genome equivalents for infection of macrophages, C. burnetii
genomic DNA was isolated with the illustraTM bacteria genomicPrep Mini Spin Kit (GE
Healthcare), and genomic equivalents were measured by quantitative PCR of the C.
burnetii dotA gene using SYBR Green, the CFX96 qPCR machine (Bio-Rad
Laboratories), and the following primers: dotA 5’ (GCGCAATACGCTCAATCACA), dotA
3’ (CCATGGCCCCAATTCTCT). L. pneumophila ΔdotA (Berger et al., 1994), ΔflaA
(Ren et al., 2006), and ΔdotA and ΔflaA harboring the pSS128 encoding a blam-RalF
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fusion plasmid on the Lp02 (thyA) background, a thymidine auxotroph derived from
strain Lp01, were cultured as a heavy patch on charcoal yeast extract agar containing
thymidine for 48 hours at 37°C (Copenhaver et al., 2014). L. pneumophila and C. burnetii
strains harboring plasmids encoding the BlaM reporter proteins were grown in the
presence of chloramphenicol at 6.75 μg/mL and 3 μg/mL, respectively.

Mammalian Cell Culture
Bone marrow was isolated from the femurs, tibia, and humeri of C57BL/6 (Jackson),
Tlr2-/- (Takeuchi et al., 1999), Tlr4-/- (Hoshino et al., 1999), Tlr2-/-Tlr4-/-, Myd88-/- (Adachi et
al., 1998), Trif-/- (Yamamoto et al., 2003), Myd88-/-Trif-/-, and Ifnar-/- (Müller et al., 1994)
mice . Bone marrow cells were differentiated into macrophages for 7-8 days in RPMI
containing 30% L929 cell supernatant and 20% FBS at 37°C in a humidified incubator
(Casson et al., 2013). Macrophages were lifted with ice-cold PBS + 2 mM EDTA and
replated one day prior to infection in RPMI containing 15% L929 cell supernatant and
10% FBS. Macrophages were plated into 48 or 24 well plates at 1.5x105 or 2.0x105 cells
per well, respectively. Macrophages were infected with various MOIs of C. burnetii and
L. pneumophila as indicated. C. burnetii and L. pneumophila bacteria were washed once
with PBS prior to infection of macrophages. After infection, cells were spun at 1200 RPM
for 5 minutes prior to incubation at 37˚C. At designated timepoints, macrophage
supernatants, whole cell lysates, or mRNA were collected.

Immunoblot Analysis
Cell lysates were collected with 1X SDS-PAGE sample buffer or supernatants were
mixed 1:1 with 2X SDS-PAGE buffer containing protease and phosphatase inhibitors.
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Samples were boiled for 5 minutes, separated by SDS-PAGE and transferred to
Immobilon P membranes (Millipore). Primary antibodies specific for phospho-p38 and
p38 MAPK (Cell Signaling Technology), caspase-1 p10 (Santa Cruz Biotechnology), IL1β (R&D Systems), and β-actin (Sigma) were used. Detection was performed with HRPconjugated anti-rabbit antibodies (Cell Signaling Technology), anti-mouse antibodies
(Cell Signaling Technology), or anti-rat antibodies (Jackson ImmunoResearch).

ELISA
Harvested supernatants from infected macrophages were assayed for cytokines using
capture and detection antibodies specific for TNF, IL-6, IL-1α, and IL-1β (BD
Biosciences).

Cytotoxicity Assay
Cells were infected with WT C. burnetii for 24 hours or treated with 0.5 μg/mL LPS for 4
hours and 2.5 mM ATP for 1 hour. Supernatants were harvested and used to measure %
cytotoxicity via lactate dehydrogenase (LDH) release using the LDH Cytotoxicity Assay
Kit (Clontech).

Measuring Intracellular Coxiella burnetii Replication
Measuring intracellular replication of C. burnetii in C57BL/6, Tlr2-/-, Tlr4-/-, Tlr2-/-Tlr4-/-,
Myd88-/-, Trif-/-, Myd88-/-Trif-/-, or Ifnar-/- BMDMs was performed as follows. Macrophages
were infected with C. burnetii Nine Mile Phase II expressing mCherry at MOI=100 in 24
well plates (Beare et al., 2011). 24 hours post-infection, cells were washed 3 times with
PBS to remove extracellular bacteria and fresh media was added to the cells every 2
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days. At designated timepoints post-infection, the extracellular media was collected and
the adherent macrophages were lysed with 1mL sterile dH2O. The lysed samples were
then combined with the extracellular media from the same well. Bacterial genomic DNA
was purified and C. burnetii genomic equivalents (GE) were measured via qPCR using
primers specific for the C. burnetii dotA gene. The fold change in bacterial GEs was
calculated as a ratio of the number of GEs on a given day to the number of GEs on day
1.

Enumeration of Coxiella burnetii-containing vacuoles by microscopy
2.0 x 105 cells were plated onto a glass coverslip per well in triplicate in 24 well plates for
each condition. Seven days post-infection, cells were washed with PBS, stained with
DAPI, and fixed with 4% paraformaldehyde. Images were taken with a Nikon Eclipse
2000E-U epifluorescence microscope and images were acquired with NIS Elements B4
4.10.01 software. Large vacuoles (> 5 μM) containing mCherry-expressing C. burnetii
were enumerated as a percentage of total DAPI-positive cells. For each coverslip,
greater than 300 cells were counted.

Quantitative RT-PCR
RNA was isolated from infected macrophages using the RNeasy Mini kit and DNasetreated using the RNase-free Dnase set (Qiagen) to remove contaminating genomic
DNA. The isolated RNA was then reverse transcribed into cDNA using Superscript II
reverse transcriptase (Invirogen). Relative mRNA abundance was measured by qPCR
using SYBR Green and the CFX96 qPCR machine (Bio-Rad Laboratories). The following
primer pairs were used: Ifnb 5’ (GCACTGGGTGGAATGAGACTATTG), Ifnb 3’
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(TTCTGAGGCATCAACTGACAGGTC), Ifna4 5’ (CCCACAGCCCAGAGAGTGACC),
Ifna4 3’ (GGCCCTCTTGTTCCCGAGGT), Hprt 5’ (GTTGGATACAGGCCAGACT), Hprt
3’ (GAGGGTAGGCTGGCCTAT). To calculate relative fold induction using the ΔΔCT
method, the cycle threshold (Ct) of a given gene was normalized to HPRT Ct and
compared to the normalized Ct in uninfected cells.

Viral Proliferation Bioassay
The viral proliferation bioassay was performed as previously described, with some
modifications as follows (Park et al., 2003). Briefly, C57BL/6 macrophages were mock
infected, treated with Poly (I:C) (Invivogen), or infected with L. pneumophila ΔflaA at
MOI=5 or WT C. burnetii NMII at MOI=50 for 24 hours. Supernatants were collected and
UV-inactivated by exposure to 600 mJoules·cm-2 UVA light in a Stratalinker 1800
(Stratagene). L2 mouse fibroblasts were treated with UV-inactivated supernatants for 24
hours and then infected with Newcastle disease virus expressing green fluorescent
protein (NDV-GFP) at an MOI of 1 plaque-forming unit (PFU)/cell. At 24 hours postinfection, cells were fixed, stained with DAPI, and examined under an Eclipse TE2000-U
epifluorescence microscope (Nikon Instruments, Inc.). Images were acquired using NIS
Elements B4 4.10.01 software (Nikon Instruments, Inc.). Mean GFP fluorescence
intensity was determined using ImageJ, with background fluorescence determined from
mock viral-infected samples. For each sample, the mean of three random fields of equal
area was quantified. Images and quantification are representative of two independent
experiments.

Effector Translocation Assay
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Translocation of BlaM-effector fusion proteins was performed as previously described
(Copenhaver et al., 2014; Newton et al., 2013). 5.0x105 BMDMs were seeded over night
in 12 well non-TC coated dishes. Cells were infected at indicated MOIs. 16 hours postinfection, cells were loaded with the fluorescent substrate CCF4-AM, using the Live
BLAzer-RET B/G Loading Kit with 15 mM probenecid, in the dark for 90 min at room
temperature (Copenhaver et al., 2014; Newton et al., 2013). Cells were gated on live
singlets that had retained the CCF4-AM dye.

Treatment of B6 Macrophages with Purified Coxiella burnetii Nine Mile phase II
LPS
LPS from Nine Mile Phase II C. burnetii was purified as previously described (Zamboni
et al., 2004) and resuspended in deionized water. C57BL/6 bone marrow derived
macrophages were plated in 96 wells at 1.0x105 cells per well for a total volume of 100
μL. Cells were treated with 0, 100, and 1000 ng/mL of C. burnetii for 24 hours. To ensure
the purified LPS was present, we tested its previously described ability to antagonize E.
coli LPS (Zamboni et al., 2004). 30 minutes post addition of C. burnetii LPS, we added 0,
0.1, 1, and 10 ng/mL E. coli LPS. Cells were incubated for 24 hours and TNF levels were
measured via ELISA.

Statistical Analysis
The plotting of data and statistical analysis were performed using GraphPad Prism
software. Statistical significance was determined using unpaired, two-tailed Student’s t
test or one-way analysis of variance (ANOVA) with Tukey’s posttest. Differences were
considered significant if the P value was <0.05.
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Results
Both TLR2 and TLR4 mediate cytokine responses to Coxiella burnetii Nine Mile
phase II in mouse macrophages.
Production of pro-inflammatory cytokines in response to C. burnetii infection has
previously been reported to depend largely on TLR2 signaling (Ammerdorffer et al.,
2014; Zamboni et al., 2004). However, the roles of other TLRs or the signaling adaptors
MyD88 or Trif in macrophage responses to C. burnetii are largely unknown. In particular,
it is unclear if TLR4 contributes to the immune response to C. burnetii. TLR4-deficient
mice have a defect in cytokine production during C. burnetii infection in vivo (Honstettre
et al., 2004), but the lipid A of C. burnetii is thought to be an antagonist of TLR4 and
macrophages lacking a functional TLR4 do not exhibit a defect in cytokine production
(Zamboni et al., 2004). Given that TLR2 responds so strongly to C. burnetii, we
wondered whether a role for TLR4 could be revealed in the absence of TLR2 signaling.
Thus, we infected B6, Tlr2-/-, Tlr4-/-, and Tlr2-/-Tlr4-/- bone marrow-derived macrophages
(BMDMs) with C. burnetii NMII and measured secreted levels of TNF and IL-6 at 24
hours post infection. We observed a significant reduction in TNF and IL-6 production in
infected Tlr2-/- BMDMs and no difference in cytokine production in infected Tlr4-/BMDMs, consistent with previous published studies (Figures 2.1A and 2.1B). However,
BMDMs lacking TLR2 still produced substantial levels of TNF and IL-6 following C.
burnetii infection at an MOI of 50, indicating that an additional TLR also contributes to
cytokine production. In contrast, BMDMs lacking both TLR2 and TLR4 did not produce
detectable levels of TNF and IL-6 in response to C. burnetii infection at an MOI of 50,
indicating a role for TLR4 in sensing C. burnetii that is unmasked in the absence of
TLR2.
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B6 BMDMs do not permit robust intracellular C. burnetii replication (Zamboni, 2004).
Restriction of C. burnetii replication is in part mediated through TLR2 signaling, as TLR2deficient BMDMs are significantly more permissive for C. burnetii replication (Zamboni et
al., 2004). To test if restriction of C. burnetii replication also involves TLR4, we infected
B6, Tlr2-/-, Tlr4-/-, and Tlr2-/-Tlr4-/- BMDMs with WT C. burnetii expressing mCherry and
measured bacterial uptake (Figure 2.8A) on day 1 post-infection, and intracellular
replication (Figure 2.1C) and vacuole formation (Figures 2.1D and 2.1E) at day 7 postinfection. Similar levels of bacterial uptake were observed for the different genotypes of
mouse macrophages. In agreement with previous findings, B6 and Tlr4-/- BMDMs limited
bacterial replication, whereas TLR2-deficient BMDMs were more permissive for
intracellular C. burnetii replication. Tlr2-/-Tlr4-/- BMDMs were not more permissive for C.
burnetii replication when compared to Tlr2-/- BMDMs, suggesting that concomitant
deletion of both TLR2 and TLR4 does not increase macrophage susceptibility to C.
burnetii replication, despite decreased cytokine production.

The TLR signaling adaptors MyD88 and Trif are critical for cytokine production
and cell-intrinsic control of intracellular Coxiella burnetii replication in mouse
macrophages.
Because TLR2 primarily signals through the adaptor protein MyD88, whereas TLR4
signals through both MyD88 and Trif (Akira, 2003), we next examined the roles of
MyD88 and Trif in mediating cytokine responses to C. burnetii. Myd88-/- BMDMs
produced significantly lower, but still substantial, levels of TNF and IL-6 compared to WT
BMDMs following C. burnetii infection at an MOI of 50 (Figures 2.2A and 2.2B). Trif-/BMDMs similarly produced significantly lower, but substantial, levels of TNF and IL-6
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compared to WT BMDMs. In contrast, Myd88-/-Trif-/- BMDMs did not produce detectable
levels of TNF or IL-6, suggesting that both MyD88 and Trif signaling contribute to
cytokine production during C. burnetii infection. Thus, in addition to confirming that TLR2
is a major sensor of C. burnetii, these data implicate a role for TLR4 and/or another Trifdependent TLR in responding to C. burnetii NMII and mediating cytokine production.
To test if MyD88 and Trif also contribute to the restriction of C. burnetii replication, we
infected B6, Myd88-/-, Trif-/-, and Myd88-/-Trif-/- BMDMs with WT C. burnetii expressing
mCherry and measured bacterial uptake (Figure 2.8B) on day 1 post-infection as well as
intracellular replication (Figure 2.2C) and vacuole formation (Figures 2.2D and 2.2E) at
day 7 post-infection. Similar levels of bacterial uptake were observed for the different
genotypes of BMDMs. When we examined the levels of intracellular C. burnetii
replication at day 7 post-infection, we found that Myd88-/- BMDMs were significantly more
permissive than B6 BMDMs, whereas Trif-/- BMDMs did not exhibit increased bacterial
growth. BMDMs deficient in both Myd88 and Trif were more permissive than MyD88deficient BMDMs for intracellular C. burnetii growth, as measured by both increased GEs
and vacuole number. These data indicate that both MyD88 and Trif mediate cytokine
production and restriction of intracellular C. burnetii replication in B6 BMDMs.

Purified Coxiella burnetii LPS does not induce TNF production.
Since we observed a role for TLR4 in the production of TNF, we wanted to test if
purified C. burnetii Nine Mile Phase II LPS was capable of stimulating TNF production in
our system. C57BL/6 failed to produce TNF in response to two concentrations of C.
burnetii LPS, 100 ng/mL or 1000 ng/mL (Figure 2.3). To confirm our sample contained
functional C. burnetii LPS, we performed an LPS antagonism assay, as C. burnetii LPS
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has been reported to be antagonistic (Zamboni et al., 2004). Cells were pretreated with
C. burnetii LPS and then stimulated with different doses of E. coli LPS ranging from 0.1
to 10 ng/mL(Zamboni et al., 2004). We saw that C. burnetii LPS antagonized the
stimulatory activity ofE. coli LPS similarly to the previous study (Figure 2.3). These data
suggest that C. burnetii LPS alone fails to stimulate TLR4. TLR4-induced TNF production
could require a second signal from TLR2 or may be stimulated by another yet-to-beidentified bacterial or host ligand.

Coxiella burnetii translocates effector proteins into B6 macrophages.
To confirm that C. burnetii in our system was capable of translocating bacterial
products into the host cell cytosol, we used a β-lactamase reporter system to measure
T4SS effector translocation. As positive and negative controls, we used the L.
pneumophila ΔflaA strain and ΔdotA strain, which lack a functional T4SS, both harboring
a plasmid encoding a translational fusion of the E. coli TEM-1 β-lactamase (BlaM) and
the T4SS effector RalF. RalF is a L. pnemophila effector that is robustly translocated into
host cells (Copenhaver et al., 2014). For C. burnetii, we used WT and icmL::Tn Nine Mile
Phase II carrying a plasmid encoding BlaM translationally fused to CBU_0077, a C.
burnetii effector protein previously shown to be translocated into macrophages at
relatively early time points, by 4 to 8 hours post-infection (Newton et al., 2013).
Translocation of the fusion proteins was detected in host cells by means of the
membrane-permeable BlaM substrate CCF4-AM (Zlokarnik et al., 1998). CCF4-AM
consists of coumarin joined to fluorescein by a β-lactam ring. When excited at 409nm,
fluorescence resonance energy transfer (FRET) between coumarin and fluorescein
results in green fluorescence emission at 518nm. T4SS-injected BlaM will cleave the

	
  

45

	
  
CCF4-AM substrate in the host cytosol and eliminate FRET, thus resulting in blue
fluorescence emission at 447nm. As expected, the L. pneumophila ΔflaA strain robustly
translocated RalF into macrophages, whereas the ΔdotA strain was unable to
translocate (Figure 2.4). At 16 hours post-infection, with the Nine Mile Phase II strains
expressing BlaM-0077, we were able to see dose-dependent injection into C57BL/6
macrophages infected with WT, but not icmL::Tn (Figure 2.4). This confirms that in our
system, C. burnetii is capable of introducing bacterial products into the cytosol of
replication-restrictive C57BL/6 macrophages.

Coxiella burnetii T4SS activity does not enhance cytokine production.
Cytosolic sensing of bacterial products translocated into the host cell cytosol by
specialized secretion systems can contribute to increased cytokine production and
restriction of bacterial replication. In the case of L. pneumophila, cytosolic sensing of
T4SS-translocated products leads to enhanced cytokine production (Shin et al., 2008).
C. burnetii NMII is capable of translocating T4SS effectors into C57BL/6 macrophages
(Newton et al., 2013), but whether cytosolic sensing of C. burnetii T4SS activity might
similarly lead to increased pro-inflammatory cytokine production is unknown. To test this
possibility, we infected WT macrophages with WT C. burnetii or T4SS-deficient C.
burnetii (icmL::Tn) containing an inactivating transposon insertion in the icmL gene
(Carey et al., 2011). We then measured production of pro-inflammatory cytokines TNF
and IL-6. As a positive control for T4SS-dependent cytokine production, we used L.
pneumophila ΔflaA, which express a functional T4SS but lack flagellin to bypass NAIP5
inflammasome activation and host cell death in B6 BMDMs (Ren et al., 2003), or L.
pneumophila ΔdotA, which lack a functional T4SS (Berger et al., 1994). As previously
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demonstrated, L. pneumophila ΔflaA infection induced increased production of TNF and
IL-6 compared to infection with L. pneumophila ΔdotA. In contrast, we did not observe
enhanced TNF or IL-6 production in BMDMs infected with WT C. burnetii compared to
infection with C. burnetii icmL::Tn in restrictive C57BL/6 or permissive Tlr2-/- (Figures
2.5A-D). Moreover, in contrast to increased T4SS-dependent expression of pro-IL-1β in
response to L. pneumophila ΔflaA compared to ΔdotA infection, we did not observe
differential expression of pro-IL-1β between WT and C. burnetii icmL::Tn (Figure 2.6H).
These findings suggest cytosolic sensing of C. burnetii’s T4SS does not lead to
increased production of the pro-inflammatory cytokines TNF, IL-6, or pro-IL-1β. We did,
however, consistently observe a slight decrease in cytokine production in cells infected
with WT C. burnetii compared to cells infected with IcmL-deficient bacteria, suggesting
that C. burnetii T4SS activity may somehow diminish production of pro-inflammatory
cytokines.

Early p38 MAPK activation in response to Coxiella burnetii infection is mediated
by TLR signaling.
Upon detection of PAMPs by surface and cytosolic PRRs, signaling events that
involve phosphorylation and activation of host MAPKs contribute to the generation of a
pro-inflammatory transcriptional response (Janeway and Medzhitov, 2002). For example,
L. pneumophila induces rapid p38 MAPK activation within 20 minutes post-infection that
involves both TLR signaling as well as cytosolic sensing of T4SS-translocated bacterial
effectors (Fontana et al., 2012; Shin et al., 2008). p38 MAPKs are activated and
contribute to cytokine production during C. burnetii infection, but the mechanistic basis
for MAPK activation in response to C. burnetii is unknown (Ammerdorffer et al., 2014;
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Barry et al., 2012; Voth and Heinzen, 2009). To test if p38 MAPK phosphorylation shortly
after C. burnetii infection requires TLR signaling, we infected B6 and Myd88-/- BMDMs
with WT C. burnetii and examined p38 MAPK phosphorylation up to two hours postinfection (Figure 2.5E). We observed robust phosphorylation of p38 MAPK in B6
macrophages, but p38 MAPK phosphorylation was attenuated in MyD88-deficient
BMDMs, suggesting that early p38 MAPK activation in response to C. burnetii is largely
TLR-dependent and is not robustly triggered by cytosolic immunosurveillance pathways.

Inflammasomes are not activated by Coxiella burnetii in mouse macrophages and
do not restrict intracellular replication.
Bacterial ligands introduced into the host cell cytoplasm by virulence-associated
specialized secretion systems can be sensed by cytosolic PRRs (Fritz et al., 2006;
Inohara et al., 2005; Ting et al., 2006). A subset of cytosolic PRRs trigger the assembly
of a multi-protein cytosolic complex termed the inflammasome. Inflammasomes recruit
and activate the host proteases caspase-1 and caspase-11, which regulate an
inflammatory cell death termed pyroptosis and promote the release of IL-1 family
cytokines, including IL-1α, IL-1β, and IL-18 (Martinon et al., 2002; Miao et al., 2010;
Rathinam et al., 2012). This inflammatory cell death can restrict intracellular bacterial
replication and contributes to a systemic in vivo immune response involving neutrophil
recruitment and IFNγ production and subsequent bacterial clearance. Infection with
T4SS-expressing L. pneumophila leads to robust activation of multiple inflammasomes,
including a flagellin-dependent NAIP5 inflammasome, an NLRP3 inflammasome that
responds to an unidentified T4SS-dependent signal, and a caspase-11 inflammasome
that detects hexa-acylated or penta-acylated lipid A (Case and Roy, 2011; Case et al.,
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2013; 2009; Casson et al., 2013; Hagar et al., 2013; Kayagaki et al., 2011; Molofsky,
2006; Ren et al., 2006; Shi et al., 2014; Zamboni et al., 2006). C. burnetii does not
contain genes encoding flagellin and thus would not be expected to activate the NAIP5
inflammasome (Seshadri et al., 2003). Furthermore, C. burnetii expresses tetra-acylated
lipid A, which is thought to be non-stimulatory for caspase-11, and thus would not be
expected to activate the caspase-11 inflammasome (Hagar et al., 2013; Kayagaki et al.,
2011; Zamboni et al., 2004). However, whether C. burnetii infection induces activation of
the NLRP3 inflammasome or other inflammasomes is unknown. To test if C. burnetii
infection of mouse macrophages leads to inflammasome activation, we first infected B6
BMDMs with C. burnetii and measured secretion of the inflammasome-dependent
cytokines IL-1α and IL-1β, as well as cell death. As a positive control for inflammasome
activation, we infected BMDMs with L. pneumophila ΔflaA, which lack flagellin and are
unable to activate the NAIP5 inflammasome but still activate the NLRP3 and caspase-11
inflammasomes. As expected, infection with L. pneumophila ΔflaA at an MOI of 5
induced robust release of both IL-1α and IL-1β (Figures 2.6A and B). In contrast, we
were unable to detect released IL-1α and IL-1β in the supernatant of C. burnetii-infected
cells even at a high MOI of 100 at 24 hours post-infection, suggesting that C. burnetii
infection fails to induce inflammasome-dependent cytokine secretion(Figures 2.6A and
2.6B). Furthermore, we did not detect cell death 24 hours post-infection in C. burnetiiinfected cells, whereas treatment with the NLRP3 inflammasome stimulus LPS + ATP
induced robust cell death (Figure 2.6C).
Inflammasome activation is a two step process that requires an initial ‘priming’ signal,
often TLR signaling, to upregulate the expression of inflammasome components,
including pro-IL-1β, followed by a second ‘activation’ signal involving cytosolic detection
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of bacterial PAMPs (Fontana and Vance, 2011). WT C. burnetii infection is capable of
priming macrophages, as measured by detection of pro-IL-1β in the lysates of B6
BMDMs infected with WT C. burnetii at MOIs ranging from 20 to 100 (Figure 2.6G);
however, the levels of pro-IL-1β induced in C. burnetii-infected B6 BMDMs even at an
MOI of 100 were substantially lower than in BMDMs infected with L. pneumophila at an
MOI of 5, indicating that C. burnetii does not prime BMDMs as robustly as L.
pneumophila. Thus, it is possible that the level of priming induced by C. burnetii infection
is insufficient for inflammasome activation and subsequent IL-1α and IL-1β release. To
test this possibility, we next pre-primed B6 BMDMs with E. coli LPS for 4 hours, an
established method of inflammasome priming that induces robust expression of pro-IL1β and other inflammasome components (Casson et al., 2013). We then infected LPSprimed cells with L. pneumophila ΔflaA or WT C. burnetii NMII and measured secreted
IL-1α and IL-1β (Figures 2.6D and 2.6E). Mock-infected, LPS-primed BMDMs did not
release IL-1α or IL-1β into the supernatant, as LPS-priming alone is insufficient for
inflammasome activation, whereas L. pneumophila ΔflaA-infected primed BMDMs
released substantial levels of IL-1α and IL-1β by 24 hours post-infection. In contrast, we
were unable to detect secreted IL-1α or IL-1β in the supernatants of LPS-primed cells
infected with WT C. burnetii at MOIs ranging from 20 to 100 for 24 hours, suggesting that
even following LPS-priming, C. burnetii NMII infection fails to induce inflammasomedependent cytokine secretion. We next examined whether the failure to detect
inflammasome-dependent cytokine secretion was due to an upstream defect in caspase1 activation by assaying for caspase-1 processing into a mature 10kD-sized fragment
(p10) and its release into the supernatant of infected cells (Figure 2.6H) Mock-infection
of LPS-primed BMDMs did not result in caspase-1 processing and release, whereas L.
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pneumophila ΔflaA infection led to caspase-1 processing into a detectable p10 form. In
contrast, caspase-1 processing was undetectable following WT C. burnetii infection at all
MOIs tested. These data indicate that C. burnetii NMII infection can lead to the
upregulation of inflammasome-related genes such as pro-IL-1β, but C. burnetii T4SS
activity does not trigger inflammasome activation following infection of mouse
macrophages. Moreover, despite similar levels of internalized bacteria at 24 hours postinfection (Figure 2.8C), we did not detect increased C. burnetii replication in Casp1-/Casp11-/- BMDMs, in contrast to Tlr2-/- BMDMs (Figure 2.6F), further demonstrating that
inflammasomes do not play a critical role in controlling intracellular C. burnetii replication
in B6 BMDMs.

Type I interferons are not robustly induced by Coxiella burnetii and do not restrict
intracellular replication in mouse macrophages.
Many intracellular bacterial pathogens stimulate the production of type I interferon
(IFN) in infected host cells (Monroe et al., 2010). Induction of type I IFNs is regulated in
part by extracellular sensors, such as TLR4, as well as cytosolic sensors, such as the
RNA sensors RIG-I and MDA-5, the DNA sensor cGAS, or the cyclic dinucleotide sensor
STING (Burdette and Vance, 2013; Dempsey and Bowie, 2015; Monroe et al., 2010;
Paludan, 2015). In some bacterial infections, such as L. pneumophila, type I IFNs
promote bacterial clearance (Coers et al., 2007; Lippmann et al., 2011; Schiavoni et al.,
2004), while in other infections, such as M. tuberculosis, activation of type I IFNs is
detrimental to the host (Manzanillo et al., 2012). Whether C. burnetii induces type I IFNs
upon infection of macrophages is unknown. To test if C. burnetii activates a type I IFN
response, we infected B6 BMDMs with WT C. burnetii and measured levels of Ifna4 and
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Ifnb mRNAs by quantitative RT-PCR (Figures 2.7A and 2.7B). We were unable to detect
transcriptional induction of IFNα4 or IFNβ 16 hours post infection, suggesting that C.
burnetii does not robustly induce expression of type I IFNs. In contrast, we observed
robust upregulation of Ifna4 and Ifnb mRNAs in response to L. pneumophila ΔflaA
infection (Figures 2.7A and 2.7B). However, it is possible that undetectable but
biologically active amounts of type I IFNs are still produced during infection.
Alternatively, it is possible that C. burnetii may induce expression of one of the other nine
known type I IFNs. We therefore used a bioassay that detects type I IFN antiviral activity
by measuring the ability of supernatants from C. burnetii-infected BMDMs to inhibit
replication of GFP-expressing Newcastle disease virus (NDV) in mouse fibroblasts (Park
et al., 2003). As expected, supernatants from BMDMs treated with the TLR3 ligand
poly(I:C) or L. pneumophila ΔflaA-infected macrophages, which both induce robust type I
IFN production, markedly decreased viral replication as measured by decreased GFP
intensity compared to mock-treated cells, confirming that these two stimuli induce IFN
production (Figures 2.7C and 2.7D). Supernatants from C. burnetii NMII-infected
BMDMs also led to decreased viral replication, although to a lesser degree, suggesting
that low, biologically active levels of type I IFN are produced during C. burnetii infection.
Since type I IFN signaling restricts the intracellular replication of L. pneumophila in
BMDMs (Coers et al., 2007), we next tested if type I IFN signaling played a similar role in
the restriction of C. burnetii by measuring replication of WT C. burnetii in B6 or Ifnar-/BMDMs, as all type I IFNs signal through the type I IFN receptor (IFNAR) (Müller et al.,
1994) . IFNAR-deficient BMDMs did not exhibit increased C. burnetii replication by day 7
post-infection (Figure 2.7E). These data demonstrate that C. burnetii does not robustly
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induce production of type I IFNs, nor are type I IFNs required to restrict intracellular C.
burnetii replication in B6 BMDMs.

Discussion
Coxiella burnetii can infect and replicate within macrophages, yet little is known about
the immune mechanisms utilized by macrophages to detect and restrict intracellular C.
burnetii replication. In our study, we aimed to identify innate immune pathways used by
B6 macrophages to detect and restrict C. burnetii NMII. B6 macrophages are not
permissive for intracellular C. burnetii growth (Zamboni et al., 2004), despite the ability of
C. burnetii to translocate T4SS effectors into these cells (Newton et al., 2013). Past
studies identified a critical role for TLR2 in enabling B6 macrophages to detect and limit
C. burnetii replication (Zamboni et al., 2004), suggesting that innate immunity plays a
key role in controlling C. burnetii infection in this cell type. However, the roles of other
TLRs and the signaling adaptors MyD88 and Trif in the innate immune response to C.
burnetii remain poorly understood. Here, we find that TLR2 and TLR4 signal in concert to
mediate proinflammatory cytokine production in response to C. burnetii NMII. The TLR
signaling adaptors MyD88 and Trif were required for this cytokine response and also
contributed to the restriction of C. burnetii replication. Furthermore, to date, whether
cytosolic immunosurveillance pathways detect bacterial products translocated by the C.
burnetii T4SS and limit C. burnetii growth in B6 macrophages is unclear. In this study,
we find that C. burnetii does not induce inflammasome activation or robust production of
proinflammatory cytokines or type I IFNs in a T4SS-dependent manner, suggesting that
C. burnetii does not robustly activate cytosolic immune sensing pathways in B6
macrophages.
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We first set out to examine the role of TLR signaling in pro-inflammatory cytokine
production and bacterial restriction in B6 BMDMs infected with C. burnetii NMII. In
agreement with previous findings (Zamboni et al., 2004), we found production of TNF
and IL-6 to be largely mediated by TLR2. Interestingly, we also uncovered a role for
TLR4 in the production of these cytokines. Deletion of TLR4 alone did not impact
cytokine production, consistent with previous findings, but concomitant ablation of TLR2
and TLR4 yielded a significant decrease in cytokine production greater than that
observed with TLR2 deficiency alone. Consistent with a role for both TLR2 and TLR4 in
immune sensing of C. burnetii NMII, we found that the adaptor proteins MyD88, which
signals downstream of both TLR2 and TLR4, and Trif, which signals downstream of
TLR4, are both required for cytokine production and restriction of bacterial replication in
infected macrophages. As we were able to uncover a role for TLR4 alone in the absence
of TLR2, this suggests that TLR4 is not essential for responding to C. burnetii, consistent
with previous findings showing that C. burnetii LPS is not stimulatory for TLR4 (Zamboni
et al., 2004). However, it is possible in the context of the whole bacterium, TLR4
somehow responds to C. burnetii, either by sensing lipid A or another PAMP, but that
TLR2 plays a more major role in sensing C. burnetii. As virulent phase I C. burnetii, in
contrast to avirulent phase II C. burnetii, inhibits p38 MAPK signaling in a TLR4dependent manner (Barry et al., 2012), further studies are necessary to test if TLR2 and
TLR4 act in concert to respond to phase I C. burnetii as well. These studies could
provide important insight into whether full-length LPS is an evasion strategy used by
phase I C. burnetii to limit TLR detection. Furthermore, we found a dominant role for TLR
signaling in mediating p38 MAPK activation in response to C. burnetii NMII infection.
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These results show that production of cytokines in response to C. burnetii infection is
highly dependent on TLR sensing.
TLRs detect extracellular PAMPs at the cell surface and within endosomes (Akira,
2003; Janeway, 1989; Janeway and Medzhitov, 2002; Medzhitov, 2007). Therefore, to
mount an immune response tailored against intracellular bacterial pathogens (Fritz et al.,
2006; Inohara et al., 2005; Ting et al., 2006), the immune system often relies on
cytosolic PRRs that respond to bacterial products introduced into the host cytosol by
many intracellular bacterial pathogens. Studies on the evolutionarily related pathogen L.
pneumophila have shown that its Dot/Icm T4SS is required for translocation of bacterial
effectors into the host cell cytosol and bacterial survival within macrophages, but also
inadvertently exposes L. pneumophila to an array of cytosolic immunosurveillance
pathways. Infection with WT L. pneumophila expressing a functional T4SS significantly
increases the production of TNF, IL-6, and IL-12 and robustly activates host MAPK
signaling, type I IFN production, and several inflammasome pathways compared to
avirulent L. pneumophila mutants lacking a functional T4SS (Casson et al., 2013; Shin et
al., 2008). Several of these pathways restrict intracellular L. pneumophila replication.
Coxiella burnetii uses a closely related Dot/Icm T4SS to translocate effector proteins into
the host cell cytosol, and C. burnetii NMII can translocate T4SS effectors into B6
BMDMs. Thus, we next asked whether cytosolic immunosurveillance pathways respond
to C. burnetii T4SS activity and restrict bacterial replication in B6 BMDMs (Newton et al.,
2013). In contrast to what we observed for L. pneumophila, we did not observe a clear
requirement for the C. burnetii T4SS in the cytokine response. Instead, we observed a
slight decrease in TNF and IL-6 production in response to T4SS-sufficient C. burnetii
compared to a T4SS-mutant strain. While the difference was not robust, it suggests the
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intriguing possibility that C. burnetii T4SS effectors inhibit cytokine production.
Inflammasomes are another cytosolic immune response that are robustly activated and
play a critical role in controlling a variety of pathogens, including L. pneumophila
(Casson and Shin, 2013). Unlike L. pneumophila, C. burnetii does not possess flagellin
(Seshadri et al., 2003), a potent activator of the NAIP5 inflammasome (Casson et al.,
2013). It is unknown, however, if C. burnetii possesses other stimulators of
inflammasome activation, as is the case for L. pneumophila. We found that while C.
burnetii induces pro-IL-1β production, it does not induce inflammasome activation. This
could be because C. burnetii does not express PAMPs that are recognized by
inflammasome-associated PRRs. For example, caspase-11 recognizes hexa- or pentaacylated LPS, but C. burnetii generates tetra-acylated LPS (Zamboni et al., 2004), which
would not be expected to activate caspase-11 (Hagar et al., 2013). Alternatively, C.
burnetii may encode T4SS effectors that actively inhibit inflammasome activation. It has
been shown, however, that primary human alveolar macrophages produce mature IL-1β
in response to C. burnetii NMII, but not phase I C. burnetii, suggesting that immune
sensing pathways in mouse and human cells may respond differently to NMII C. burnetii
(Graham et al., 2013). Our findings that C. burnetii does not robustly induce
inflammasome activation in mouse cells may provide some insight into the observation
that C. burnetii does not elicit robust neutrophil recruitment during in vivo infection of
mice (Elliott et al., 2013), as inflammasome-derived IL-1 is a critical regulator of
neutrophil recruitment during pulmonary L. pneumophila infection (Barry et al., 2013;
Casson et al., 2013; LeibundGut-Landmann et al., 2011; Mascarenhas et al., 2015). Our
findings raise the intriguing possibility that C. burnetii has evolved strategies to evade or
actively inhibit cytosolic innate immune detection.

	
  

56

	
  
Many intracellular bacteria induce cytosolic immunosurveillance pathways that lead to
type I IFN expression, and this response can be both beneficial to the host by limiting
intracellular bacterial replication, as is the case for L. pneumophila (Schiavoni et al.,
2004), or detrimental to the host, as is the case for M. tuberculosis (Manzanillo et al.,
2012), by promoting intracellular bacterial replication. It is unknown, however, if type I
IFNs are induced or play a role in controlling C. burnetii infection. Our studies indicate
that C. burnetii infection induces very low, but biologically active levels of type I IFNs.
Furthermore, we found that BMDMs lacking the type I IFN receptor did not exhibit
increased bacterial replication, suggesting that type I IFNs do not participate in restricting
C. burnetii replication in B6 macrophages.
As our studies suggested a more prominent role for TLRs rather than cytosolic
immune sensing pathways in responding to C. burnetii, we next examined the
mechanistic basis underlying the link between TLR recognition and control of bacterial
replication. Given that our data and other published studies demonstrated a critical role
for TLR signaling in mediating production of proinflammatory cytokines during C. burnetii
infection, we wondered whether cytokines play a role in restricting C. burnetii replication.
Interestingly, BMDMs lacking only Trif did not have a defect in limiting intracellular C.
burnetii replication despite having a defect in TNF production, whereas MyD88-deficient
BMDMs had a defect in both TNF production and control of C. burnetii replication that
resembles Tlr2-/- BMDMs. We were able to uncover a role for Trif in limiting replication of
C. burnetii only when we deleted both Trif and MyD88, which led to increased bacterial
replication compared to deletion of MyD88 alone. These findings suggest that in addition
to TNF production, TLR2 and MyD88 signaling are required for other antibacterial
effector mechanisms that restrict C. burnetii.
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In conclusion, our findings highlight the importance of TLR signaling in enabling B6
macrophages to restrict C. burnetii NMII. Our data also indicate that C. burnetii NMII
T4SS activity does not robustly trigger several cytosolic immunosurveillance pathways
that we examined, nor do these pathways play a major role in the control of intracellular
C. burnetii replication in B6 macrophages. Our studies provide further insight into innate
immune pathways used by macrophages to sense and restrict the replication of this
poorly understood pathogen.
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Figure 2.1 TLR2 and TLR4 mediate immune responses to Coxiella burnetii in
mouse macrophages (A and B) C57BL/6, Tlr2-/-, Tlr4-/-, and Tlr2-/-Tlr4-/- bone marrowderived macrophages (BMDMs) were infected with WT C. burnetii NMII at MOI=5 or 50
for 24 hours. Levels of TNF and IL-6 in the supernatants were measured by ELISA.
Graphs show the mean ± SEM of triplicate wells. Representative of three independent
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experiments. (C) C57BL/6, Tlr2-/-, Tlr4-/-, and Tlr2-/-Tlr4-/- BMDMs were infected with WT
C. burnetii NMII at MOI=100. At days 1 and 7 post-infection, bacterial uptake and
replication was measured as genomic equivalents (GEs) by qPCR. Graphs show the fold
change in GEs on day 7 relative to GEs on day 1 ± SEM of triplicate wells. (D) 7 days
post-infection, BMDMs of the indicated genotypes infected with mCherry-expressing WT
C. burnetii NMII at MOI=100 were fixed, stained with DAPI, and examined by
fluorescence microscopy. The number of mCherry-expressing C. burnetii-containing
vacuoles was enumerated and calculated as a percentage of the total cell number.
Graphs show the mean percentage of cells containing C. burnetii vacuoles ± SEM of
triplicate coverslips. At least 300 cells were counted per coverslip. Representative of two
independent experiments. (E) Representative fluorescence micrographs of mouse
BMDMs of the indicated genotypes infected with mCherry-expressing C. burnetii (Cb) at
MOI=100 and fixed and stained with DAPI on day 7 post-infection. Images were taken at
40X magnification. Scale bars represent 25 µM. *p<0.05, **p<0.01, ***p<0.001, ns=no
significance.
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Figure 2.2 Myd88 and Trif are required for cytokine production and the restriction
of intracellular growth (A and B) C57BL/6, Trif-/-, Myd88-/-, and Myd88-/-Trif-/- BMDMs
were infected with WT C. burnetii NMII at MOIs= 5 and 50 for 24 hours. Levels of TNF
and IL-6 in the supernatants were measured by ELISA. Graphs show the mean ± SEM
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of triplicate wells. Representative of two independent experiments (C) C57BL/6, Trif-/-,
Myd88-/-, and Myd88-/-Trif-/- BMDMs were infected with WT C. burnetii NMII at MOI=100.
At days 1 and 7 post-infection, bacterial uptake and replication was measured as
genomic equivalents (GEs) by qPCR. Graphs show the fold change in GEs relative to
the GEs measured on day 1 ± SEM of triplicate wells. (D) ) 7 days post-infection,
BMDMs of the indicated genotypes infected with mCherry-expressing WT C. burnetii
NMII at MOI=100 were fixed, stained with DAPI, and examined by fluorescence
microscopy. The number of C. burnetii-containing vacuoles was enumerated and
calculated as a percentage of the total cell number on day 7 post-infection. Graphs show
the mean percentage of cells containing C. burnetii vacuoles ± SEM of triplicate
coverslips. At least 300 cells were counted per coverslip. Representative of two
independent experiments. (E) Representative fluorescence micrographs of BMDMs of
the indicated genotypes infected with mCherry-expressing C. burnetii (Cb) at MOI=100
and fixed and stained with DAPI on day 7 post-infection. Images were taken at 40X
magnification. Scale bars represent 25 µM. *p<0.05, **p<0.01, ***p<0.001, ns=no
significance.
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Figure 2.4 C. burnetii’s T4SS is capable of injecting effectors into C57BL/6 BMDMs
C57BL/6 BMDMs were treated with RPMI or infected, and ΔflaA and ΔdotA strains
expressing BlaM-RalF MOI=5, or with WT and icmL::Tn expressing BlaM-CBU_0077 at
MOI= 5, 50 and 100. 16 hours post infection Cells were then loaded with CCF4-AM and
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analyzed by flow cytometry. Cells positive for cleaved CCF4-AM (blue) fluorescence
were gated and the percentage injection is denoted in each gate. Experiment is
representative of two experiments.
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Figure 2.5 C. burnetii T4SS expression does not lead to enhanced cytokine
production or early p38 MAPK phosphorylation. (A and B) C57BL/6 BMDMs were
infected with L. pneumophila (Lp) ΔflaA or ΔdotA at MOI=5, or WT C. burnetii (Cb) or
icmL::Tn at MOI=5 or 50 for 24 hours. Levels of (A) TNF and (B) IL-6 in the supernatants
were measured by ELISA. Graphs show the mean ± SEM of triplicate wells.
Representative of three independent experiments.(C and D) C57BL/6 BMDMs and Tlr2-/were infected with WT C. burnetii (Cb) or icmL::Tn at MOI= 50 for 24 hours. Levels of (C)
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TNF and (D) IL-6 in the supernatants were measured by ELISA. Graphs show the mean
± SEM of triplicate wells. Representative of two independent experiments (E)
Immunoblot analysis of phosphorylated and total p38 MAPK in cell lysates from C57BL/6
and Myd88-/- BMDMs that were mock-infected or infected with WT C. burnetii NMII at
MOI=50 for 0, 15, 30, or 120 minutes. Representative of two independent experiments.
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Figure 2.6 Coxiella burnetii infection does not induce detectable inflammasome
activation. (A and B) Unprimed C57BL/6 BMDMs were mock-infected, infected with L.
pneumophila ΔflaA at MOI=5, or infected with WT C. burnetii NMII at MOI= 20, 50, or
100 for 24 hours. Levels of (A) IL-1α and (B) IL-1β were measured in the supernatants
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by ELISA. Graphs show the mean ± SEM of triplicate wells. Representative of three
independent experiments. (C) C57BL/6 BMDMs were treated with 0.5 ug/mL LPS for 4
hours followed by 2.5mM ATP for one hour or infected with WT C. burnetii NMII at
MOI=50 for 24 hours. % cytotoxicity was measured via LDH release. Graph shows the
mean ± SEM of triplicate wells. (D and E) C57BL/6 BMDMs were first primed with 0.5
ug/mL LPS for 4 hours and then either mock-infected, infected with L. pneumophila
ΔflaA at MOI=5, or infected with WT C. burnetii at MOIs=20, 50, 100 for 24 hours. Levels
of (D) IL-1α and (E) IL-1β were measured in the supernatants by ELISA. Graphs show
the mean ± SEM of triplicate wells. Representative of two independent experiments. (F)
C57BL/6, Tlr2-/-, and Casp1-/-Casp11-/- BMDMs were infected with WT NMII C. burnetii at
MOI=100. At days 1 and 7 post-infection, bacterial uptake and replication was measured
as genomic equivalents (GEs) by qPCR. Graphs show the fold change in GEs on day 7
relative to GEs on day 1 ± SEM of triplicate wells. (G) Immunoblot analysis of pro-IL-1β
and actin in cell lysates from unprimed C57BL/6 BMDMs that were mock-infected or
infected with L. pneumophila ΔflaA or ΔdotA at MOI=5, or WT C. burnetii or icmL::Tn at
MOI=20, 50, or 100 for 24 hours. Representative of two independent experiments.
(H) Immunoblot analysis of processed caspase-1 (casp-1 p10) in the supernatant of
primed C57BL/6 BMDMs and pro-IL-1β and actin in the cell lysate. Representative of
two independent experiments.
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Figure 2.7 Coxiella burnetii infection does not induce robust type I interferon
production and intracellular replication is not restricted by type I interferon
signaling. (A and B) C57BL/6 BMDMs were mock-infected, infected with L.
pneumophila ΔflaA at MOI=10, or infected with WT C. burnetii NMII at MOI=10, 50, or
100 for 16 hours. Fold-induction of Ifna4 and Ifnb mRNAs were measured via qRT-PCR.
Graphs show the mean ± SEM of triplicate wells. Representative of two independent
experiments. (C) Supernatants from C57BL/6 BMDMs that were mock-infected, infected
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with L. pneumophila ΔflaA at MOI=10, or infected with WT C. burnetii NMII at MOI=50
for 16 hours were incubated with L2 mouse fibroblasts for 24 h. L2 cells were then
infected with NDV-GFP at an MOI=1. As a positive control, L2 cells were treated with
supernatants from C57BL/6 BMDMs stimulated with poly (I:C) for 16 hours. At 24 hours
post-infection, cells were fixed, stained with DAPI, and examined for levels of NDV-GFP
replication by fluorescence microscopy. Shown are representative fluorescence
micrographs. (D) Graphs of mean GFP fluorescence from each sample quantified with
ImageJ software. Representative of two independent experiments. (E) C57BL/6, Ifnar-/-,
or Myd88-/-Trif-/- BMDMs were infected with WT C. burnetii NMII at MOI=100. C. burnetii
GEs were measured qPCR on days 1 and 7 post-infection. Graphs show the fold change
in GEs relative to day 1 ± SEM of triplicate wells. Representative of two independent
experiments.
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Abstract
Pathogen activation of surface and cytosolic sensors triggers a variety of innate immune
responses. Our studies described in the previous chapter have shown that Coxiella
burnetii does not robustly activate cytosolic production of pro-inflammatory cytokines, nor
does it activate the inflammasome. Instead, the innate immune response to C. burnetii
relied largely on TLR-mediated detection, with TLR2 playing the dominant role in the
production of pro-inflammatory cytokines and cell-intrinsic control of C. burnetii
replication in vitro. Building upon these observations, we were further able to implicate
TNF as a mediator of cell-intrinsic control of bacterial replication, as TNF-deficient
macrophages were permissive for C. burnetii replication. Furthermore, we found that
soluble TNF is able to restrict C. burnetii replication in Tlr2-/- macrophages. To elucidate
the mechanism by which TNF mediates cell-intrinsic control of C. burnetii replication, we
tested three possible TNF-mediated bacterial restriction mechanisms: cell death,
production of ROS and RNS, and Guanylate Binding Proteins (GBPs). We found that C.
burnetii does not induce robust cell death, indicating that TNF-induced extrinsic
apoptosis and programmed necrosis are not major control mechanisms. We found C.
burnetii induces RNS in a TNF-dependent manner. C. burnetii also induces whole cell
ROS, which plays a role in restricting bacterial replication. GBP1 and GBP2 are induced
by C. burnetii infection, but we did not find a role for these or three additional GBPs in
bacterial restriction. Overall, these findings implicates the cytokine TNF, which is
induced by C. burnetii in a TLR-dependent manner, as mediating restriction of C. burnetii
replication and further examines possible mechanisms of TNF-mediated restriction.
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Introduction
The downstream consequences of cell surface and cytosolic immune detection are
critical for successful pathogen clearance. Following pathogen activation of cell surface
and cytosolic immune sensors, immune cells release a set of cytokines and chemokines.
These cytokines and chemokines, in turn, can signal to other cells to induce an cellextrinsic immune response or signal back to the compromised cell to induce an cellintrinsic immune response (Kawai and Akira, 2009).
Tumor necrosis factor (TNF) is a well-studied cytokine that is expressed in response
to a wide array of pathogens (Akira, 2003). In the context of bacterial infection, PAMPs
stimulate TLR and cytosolic immune receptors to activate the NF-κB and MAPK
signaling pathways to induce the transcription of TNF (Akira, 2003), with macrophages
thought to be a major source of TNF (Wajant et al., 2003). TNF is expressed as a type II
transmembrane protein that arranges into homotrimers (Kriegler et al., 1988; Tang et al.,
1996). The soluble form is released via proteolytic cleavage by the metalloprotease TNF
alpha-converting enzyme (TACE) (Black et al., 1997). Two TNF receptor (TNF-R) family
members, TNF-R1 and TNF-R2, bind soluble and membrane-bound TNF and induce a
variety of cell-intrinsic and cell-extrinsic immune responses (Locksley et al., 2001). While
membrane-bound TNF strongly binds both TNF-R1 and TNF-R2 receptors, soluble TNF
preferentially signals thought TNF-R1 (Grell et al., 1995; Wallach et al., 1991). TNF-R1 is
ubiquitously expressed on most cell types, and TNF-R2 is only expressed on immune
cells (Locksley et al., 2001). The activity of TNF is broad and it has been found to play a
major role in pathogen and tumor clearance (Wajant et al., 2003). Overproduction or
prolonged production of TNF can drive pathological inflammation leading to septic shock
or a number of autoimmune pathologies including rheumatoid arthritis and inflammatory
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bowel disease (Blam et al., 2001; Taylor et al., 2000). Several anti-TNF therapies have
been developed to decrease TNF-dependent autoimmune inflammation (Taylor, 2001).
These therapies have proven effective at alleviating the symptoms of many autoimmune
diseases, but have also been linked to increased susceptibility to certain pathogens,
notably M. tuberculosis and L. pneumophila (Lanternier et al., 2013; Wagner et al.,
2002). This recent phenomenon highlights TNF’s importance in protection against
intracellular bacteria.
TNF induces a host of cell-intrinsic immune responses that aid in the clearance of
pathogens, including but not limited to: apoptotic and necroptotic cell death (SchulzeOsthoff et al., 1998; Tartaglia et al., 1993); induction of reactive oxygen (ROS) and
reactive nitrogen (RNS) species (Chakravortty and Hensel, 2003; Han et al., 2009); and
the induction of guanylate binding proteins (GBPs) (Vestal and Jeyaratnam, 2011). TNFinduced cell death occurs in two forms: caspase-8 mediated extrinsic apoptosis and
caspase-independent programmed necrosis. TNF binding alone induces pro-survival
cascades which upregulate anti-apoptotic proteins, such as c-FLIP (Wajant et al., 2003).
c-FLIP shares sequence homology with the death caspase, caspase-8, but lacks a
catalytic domain. It binds caspase-8 to prevent caspase-8::caspase-8 homodimerization
and subsequent activation (Micheau and Tschopp, 2003; Schulze-Osthoff et al., 1998).
When host protein synthesis disrupted and c-FLIP is not upregulated, TNF signaling
induces caspase-8 activation. Active caspase-8 leads to the processing and activation of
the terminal death caspase, caspase-3, which initiates DNA fragmentation, membrane
blebbing, and cell death. Caspase-8 can activate caspase-3 via direct processing or
through the mitochondrial pathway, whereby cytochrome C released from permeabilized
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mitochondria activates caspase-9, which then activates caspase-3 to initiate cell death
(Micheau and Tschopp, 2003).
Programmed necrosis, or necroptosis, occurs as a backup when extrinsic apoptosis is
inhibited by viral inhibitors such as vICA and CrmA (Ray and Pickup, 1996; Skaletskaya
et al., 2001). Necroptosis can be induced by TNF, Toll-like receptors (TLR3 and TLR4),
or DNA sensors (DAI) (Vandenabeele et al., 2010). When caspase-8 activation is
inhibited, TNF bound to TNFR-1 is internalized and initiates the assembly of a RIPK1RIPK3 complex, termed the necrosome. In this complex, both RIPK1 and RIPK3 are
phosphorylated and initiate a series of necroptotic events that lead to cell death and the
release of alarmins, such as IL-1α, IL-33, and Danger Associated Molecular Patters
(DAMPs), such as heat shock proteins and ATP (Vandenabeele et al., 2010). DAMPs
have the potential to trigger surface and cytosolic immune receptors as well. Both
apoptosis and necroptosis are thought to control intracellular pathogens by eliminating
their replicative niche.
TNF also has the potential to induce ROS and RNS, which have a broad spectrum of
anti-microbial activities (Wajant et al., 2003). ROS is generated by the constitutively
expressed NADPH phagocytic oxidase (Phox), while RNS is generated by inducible nitric
oxide synthase (iNOS) (Bylund et al., 2010; Nathan and Shiloh, 2000). The formation of
the phox complex produces oxygen radicals via electron transfer, which in turn
spontaneously generate hydrogen peroxide intermediates. Highly toxic hydroxyl radicals
and hypochlorous acid are further generated via the Fenton reaction or by cellular
myeloperoxidase (MPO) (Imlay and Linn, 1988; Imlay, 2008; Tlili et al., 2011). These
reactive oxygen intermediates likely target bacterial DNA and can also act as signaling
molecules to induce production of inflammatory cytokines and cell death. RNS
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production requires the de novo synthesis of inducible nitric oxide synthase (iNOS),
which contains a N-terminal oxygenase and a C-terminal reductase. Upon expression,
iNOS forms homodimers and localizes to the phagosome in an actin-dependent manner
to synthesize nitric oxide radicals from L-arginine substrate (Albakri and Stuehr, 1996;
Baek et al., 1993; Davis et al., 2007). Nitrogen radicals target a variety of bacterial
components, including bacterial DNA, proteins, and lipids. Bacterial death and replication
inhibition results primarily via disruption of components of the bacterial respiration
pathway (Nathan and Shiloh, 2000).
Guanylate binding proteins (GBPs) are additional cell-intrinsic immune effectors that
can be activated by TNF (Martens and Howard, 2006). Mice encode 11 GBPs (mGBP-1
to mGBP11), while humans encode 7 GBPs (hGBP-1 to hGBP-7) (Olszewski et al.,
2006). GBPs are classically thought to be induced by Type I and Type II interferons, but
select GBPs have been shown to be induced by IL-1α, IL-1β and TNF (Vestal and
Jeyaratnam, 2011). Upregulated GBPs are targeted to cellular membranes by
isoprenylation, which involves the addition of a C-15 farnesyl or C-20 geranylgeranyl lipid
moieties to the cysteine residue in the conserved, C-terminal CaaX sequence (Vestal
and Jeyaratnam, 2011). Both mice and human GBPs have been implicated in the control
of intracellular pathogens (Nguyen et al., 2002).For example, hGBP-1 and hGBP-2
inhibit replication of Chlamydia spp (Tietzel et al., 2009); mGBP-2 controls replication of
Toxoplasma gondii (Degrandi et al., 2013); and mGBP-5 promotes Salmonella
Typhimurium-induced pyroptosis (Pilla et al., 2014).
C. burnetii has evolved strategies to subvert some of these pathways. It is wellcharacterized that C. burnetii inhibits artificially induced intrinsic apoptosis through the
T4SS effectors AnkG, CaeA, and CaeB (Klingenbeck et al., 2013; Lührmann et al.,
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2010). To date, only one study has offered insight into TNF-mediated extrinsic apoptosis.
In that study, THP-1 cells infected with C. burnetii were treated with recombinant TNF
and cyclohexamide and reduced cleavage of PARP, a terminal marker of apoptosis, was
observed (Voth et al., 2007). This study, however, did not link this inhibition to a
functional T4SS, nor did it show C. burnetii has the potential to induce caspase-8
mediated apoptosis occurs. Another study also found that at a relatively early time point,
24 hours post-infection, C. burnetii induces a caspase-independent form of cell death
that is partially mediated by TNF (Zhang et al., 2012). These studies offer the possibility
of both apoptotic and necroptotic cell death as mechanisms to control C. burnetii or
pathways that are evaded by C. burnetii.
Studies on the role and significance that ROS and RNS play in the restriction of C.
burnetii have varying conclusions. Some studies concluded that C. burnetii does not
elicit a detectible oxidative burst in monocytes and therefore does not produce either
ROS or RNS in human neutrophils or macrophages (Akporiaye et al., 1990;
Dellacasagrande et al., 1999). Moreover, C. burnetii growth did not differ between
monocytes from healthy human donors and those with chronic granulomatous disease,
which lack a functional NADPH (Akporiaye et al., 1990). Other studies with macrophages
treated with exogenous IFNγ showed C. burnetii infection did induce both ROS and
RNS, which were both shown to play a role in growth restriction upon stimulation in the
presence of exogenous IFNγ (Brennan et al., 2004; Zamboni and Rabinovitch, 2003).
Like many pathogens, C. burnetii has evolved strategies to combat ROS and RNS
stress. It was shown that phagocytosis of C. burnetii by neutrophils prevented assembly
of the NADPH oxidase on the phagosomal membrane via an unknown mechanism,
reducing whole cell levels of ROS (Siemsen et al., 2009). It was also demonstrated that
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C. burnetii secretes an acid phosphatase into the vacuole that reduces neutrophil ROS
(Hill and Samuel, 2011). This C. burnetii enzyme may prevent the phosphorylation of an
NADPH component. However, the role of ROS and RNS in the context of C. burnetii
infection of macrophages and endogenously produced TNF remain poorly understood.
The role of GBPs in C. burnetii infection have not been studied. Because C. burnetii
forms a large vacuole that acquires membrane from a variety of sources and fusion
events, it is likely that GBPs are recruited to the vacuole in some capacity. Whether
infection with C. burnetii induces the expression of these GBPs or if these proteins
promote or inhibit bacterial replication is unknown.
In this study, we found a role for soluble TNF in the cell-intrinsic inhibition of C.
burnetii Nine Mile phase II replication within B6 macrophages. We previously showed
that C. burnetii does not induce cytosolic-mediated immune responses, nor Type I
interferon. We did find a role for TLR-dependent restriction mediated by both adaptors
Myd88 and Trif and implicated both TLR2 and TLR4 in the production of TNF. Building
upon this, we found TNF plays a critical role in in vitro control of C. burnetii infection. We
then analyzed three possible cell-intrinsic effector pathways by which TNF could be
restricting bacterial replication: cell death, ROS and RNS, and GBP induction.

Materials and Methods
Bacteria Strains
All experiments in this study used Coxiella burnetii Nine Mile Phase II (clone 4; RSA
439). For C. burnetii infections, acidified citrate cysteine medium (ACCM-2) was
inoculated with WT C. burnetii (Omsland et al., 2013) or WT C. burnetii expressing
mCherry (Beare et al., 2009). C. burnetii was grown at 37°C in 5% CO2 and 2.5% O2 for
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6 days to late log phase (~1.0x109 bacteria/mL) (Omsland et al., 2013). One day after
inoculation, chloramphenicol (2.5 μg/mL) was added to mCherry cultures. To quantify C.
burnetii genome equivalents for infection of macrophages, C. burnetii genomic DNA was
isolated with the illustraTM bacteria genomicPrep Mini Spin Kit (GE Healthcare), and
genomic equivalents were measured by quantitative PCR of the C. burnetii dotA gene
using SYBR Green, the CFX96 qPCR machine (Bio-Rad Laboratories), and the following
primers: dotA 5’ (GCGCAATACGCTCAATCACA), dotA 3’ (CCATGGCCCCAATTCTCT).

Mammalian Cell Culture
Bone marrow was isolated from the femurs, tibia, and humeri of C57BL/6 (Jackson),
Tlr2-/-, Tnf-/- (Pasparakis et al., 1996), GBPChrm3-/- (Yamamoto et al., 2003), and gp91phox/-

(Pollock et al., 1995) mice. Bone marrow cells were differentiated into macrophages for

7-8 days in RPMI containing 30% L929 cell supernatant and 20% FBS at 37°C in a
humidified incubator (Casson et al., 2013). Macrophages were lifted with ice-cold PBS +
2 mM EDTA and replated one day prior to infection in RPMI containing 15% L929 cell
supernatant and 10% FBS. Macrophages were plated into 96, 48 or 24 well plates at
1.0x105, 1.5x105 or 2.0x105 cells per well, respectively. C. burnetii were washed once
with PBS prior to infection of macrophages, and macrophages were infected with various
MOIs of C. burnetii. C. burnetii were washed once with PBS prior to infection of
macrophages. After infection, cells were spun at 1200 RPM for 5 minutes prior to
incubation at 37˚C. At designated timepoints, macrophage supernatants, whole cell
lysates, or mRNA were collected.

Measuring Intracellular Coxiella burnetii Replication
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Measuring intracellular replication of C. burnetii in C57BL/6, Tlr2-/-, Tnf-/-, GBPChrm3-/-, and
gp91phox-/- BMDMs was performed as follows. Macrophages were infected with C.
burnetii Nine Mile Phase II expressing mCherry at MOI=100 in 24 well plates. 24 hours
post-infection, cells were washed 3 times with PBS to remove extracellular bacteria and
fresh media was added to the cells every 2 days. At designated timepoints postinfection, the extracellular media was collected and the adherent macrophages were
lysed with 1mL sterile dH2O. The lysed samples were then combined with the
extracellular media from the same well. Bacterial genomic DNA was purified and C.
burnetii genomic equivalents (GE) were measured via qPCR using primers specific for
the C. burnetii dotA gene. The fold change in bacterial GEs was calculated as a ratio of
the number of GEs on a given day to the number of GEs on day 1. For experiments
examining the role of TNF in restricting C. burnetii growth, 10ng/mL recombinant mouse
TNF (Biolegend) or supernatants from B6 macrophages infected with C. burnetii for 24
hours were added to C. burnetii-infected macrophages on day 1 and day 5 postinfection.

Enumeration of Coxiella burnetii-containing vacuoles by microscopy
2.0 x 105 cells were plated onto a glass coverslip per well in triplicate in 24 well plates for
each condition. Seven days post-infection, cells were washed with PBS, stained with
DAPI, and fixed with 4% paraformaldehyde. Images were taken with a Nikon Eclipse
2000E-U epifluorescence microscope and images were acquired with NIS Elements B4
4.10.01 software. Large vacuoles containing mCherry-expressing C. burnetii were
enumerated as a percentage of total DAPI-positive cells. For each coverslip, greater
than 300 cells were counted.
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TUNEL Assay
2.0 x 105 cells were plated onto a glass coverslip per well in triplicate in 24 well plates for
each condition. Cells were either mock infected with RPMI, treated with 1000 μM
staurosporine for 4 hours, or for infected with WT C. burnetii at MOI=100 for 24 hours.
Post-treatment cells were washed with PBS and fixed with 4% paraformaldehyde. Cells
were incubated with TUNEL enzyme and TUNEL dye in a humidified incubator for sixty
minutes. Coverslips were mounted with Prolong-gold with DAPI. Images were taken with
a Nikon Eclipse 2000E-U epifluorescence microscope and images were acquired with
NIS Elements B4 4.10.01 software. TUNEL positive cells were enumerated as a
percentage of total DAPI-positive cells. For each coverslip, greater than 300 cells were
counted.

Quantitative RT-PCR
RNA was isolated from infected macrophages using the RNeasy Mini kit and DNasetreated using the RNase-free Dnase set (Qiagen) to remove contaminating genomic
DNA. The isolated RNA was then reverse transcribed into cDNA using Superscript II
reverse transcriptase (Invirogen). Relative mRNA abundance was measured by qPCR
using SYBR Green and the CFX96 qPCR machine (Bio-Rad Laboratories). The following
primer pairs were used: Nos2 5’ (ACATCGACCCGTCAACAGTAT), Nos2 3’
(CAGAGGGGTAGGCTTGTCTC), mGBP1 5’ (AGATGCCCTTGGTGTGAGAC), mGBP1
3’ (CTCTACCGCACAGGCAATC), mGBP2 5’ (TCTACCCCACTCTGGTCAGG), mGBP2
3’ (CAGCATAGGAACCATCAACCA), Hprt 5’ (GTTGGATACAGGCCAGACT), Hprt 3’
(GAGGGTAGGCTGGCCTAT). To calculate relative fold-induction using the ΔΔCT
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method (Shin et al., 2008), the cycle threshold (Ct) of a given gene was normalized to
HPRT Ct and compared to the normalized Ct in uninfected cells.

Measurement of Nitric Oxide
Macrophages were infected at indicated MOIs in 96 well plates at 1.5x105 cells per well
in 150 uL media. At indicated time points, nitrite (NO2-) levels were measured with the
Griess reagent system according to the manufacturers guidelines (Promega).

Measurment of Whole Cell ROS
6.0x105 macrophages were plated in 12-well non-tissue culture plates. Cells were treated
with 0.5 μg/mL for 6 hours or infected with WT C. burnetii MOI=100 for 16 hours. Cells
were incubated with 2.5 μM CM-H2DCFDA and HBSS containing Ca, Mg, and glucose
for 20 min in 37° C for 20 minutes in a humidified incubator. Levels of whole cell ROS
were measured by flow cytometry.

Statistical Analysis
The plotting of data and statistical analysis were performed using GraphPad Prism
software. Statistical significance was determined using unpaired, two-tailed Student’s t
test or one-way analysis of variance (ANOVA) with Tukey’s posttest. Differences were
considered significant if the P value was <0.05.

Results
TNF is critical for cell-intrinsic control of Coxiella burnetii Nine Mile phase II
replication.
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The addition of exogenous TNF along with IFNγ to a mouse fibroblast cell line or human
monocytes has been shown to restrict intracellular C. burnetii replication (Ghigo et al.,
2001; Howe et al., 2002). Furthermore, a previous study showed that antibody-mediated
neutralization of TNF led to increased C. burnetii replication in human monocytes (Howe
et al., 2002). Whether endogenous levels of TNF produced by B6 BMDMs during
infection contribute to the restriction of intracellular C. burnetii replication is unknown;
moreover, it is unknown if TNF alone is sufficient to inhibit intracellular replication in this
cell type. To test this, we infected Tnf-/- BMDMs with WT C. burnetii and measured
bacterial uptake (Figure 3.6A), intracellular replication (Figure 3.1A), and vacuole
formation (Figures 3.1C and 3.1D). We observed robust intracellular bacterial growth in
Tnf-/- BMDMs, with a greater than 25-fold increase in GE and an increase in C. burnetiicontaining vacuoles by day seven post-infection, suggesting that endogenously
produced TNF plays a major role in the ability of B6 BMDMs to restrict C. burnetii
replication. To confirm this restriction was mediated by soluble TNF, we added 10ng/mL
recombinant TNF to C. burnetii-infected Tnf-/- BMDMs at days 1 and 5 post-infection
(Figures 3.1B-D). We found that the addition of recombinant TNF restored the ability of
Tnf-/- BMDMs to restrict C. burnetii replication, as measured by a decrease in GEs and
the percentage of C. burnetii vacuoles, suggesting that the deficiency in TNF production
accounts for the increased susceptibility of Tnf-/- BMDMs, and that soluble TNF is
sufficient to inhibit C. burnetii replication in these cells. Furthermore, the addition of
supernatants from B6 BMDMs infected with C. burnetii for 24 hours restored the ability of
Tnf-/- BMDMs to restrict intracellular C. burnetii growth, further supporting that
intracellular restriction of C. burnetii replication by B6 BMDMs is mediated by secreted
factor(s), one of which is TNF. Finally, we examined whether the defect in the ability of
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Tlr2-/- BMDMs to control C. burnetii could be complemented by exogenous treatment
with rTNF or the supernatants from C. burnetii-infected B6 BMDMs (Figure 3.1E). In
contrast to mock-treated Tlr2-/- BMDMs, Tlr2-/- macrophages treated with rTNF or
supernatants from C. burnetii-infected BMDMs were able to restrict intracellular C.
burnetii replication to levels comparable to B6 BMDMs. Taken together, our data suggest
that endogenous TNF produced in response to TLR sensing of C. burnetii infection
critically contributes to the ability of B6 macrophages to control C. burnetii replication.
Furthermore, these data indicate that the inability of Tlr2-/- BMDMs to control C. burnetii
replication is primarily due to a defect in TNF production, as addition of exogenous TNF
restored the ability of these cells to limit intracellular C. burnetii replication.

Coxiella burnetii phase II does not induce cell death in B6 macrophages
Cell death is one mechanism by which cells control pathogens. TNF can induce both
non-inflammatory apoptosis and inflammatory necrosis. One study in THP-1 cells found
that C. burnetii induces cell death 24 hours post infection (Zhang et al., 2012), while
another study showed that C. burnetii inhibits extrinsic apoptosis, which is mediated by
TNF signaling to caspase-8 (Voth et al., 2007). Cell death in B6 BMDMs infected with C.
burnetii, however, has not been studied. We found no cell death in C. burnetii-infected
B6 macrophages using the LDH bulk assay at 24 hours post-infection (Figure 2.6C), but
wanted to test with a more sensitive single cell assay whether cell death was occurring.
In order to determine if TNF-dependent cell death occurs and is a possible mechanism
of control for C. burnetii, we employed the TUNEL method of staining. We were unable
to detect cell death at 24 hours post-infection at an MOI=100, the same MOI used in our
growth curves (Figure 3.2A and 3.2B). These data, coupled with our previous findings
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using the LDH cytotoxicity assay (Figure 2.6C), suggest that TNF-mediated cell death is
not a major mechanism by which B6 macrophages control C. burnetii.

Coxiella burnetii infection induces the production of iNOS and Reactive Nitrogen
Species (RNS) in B6 macrophages in a TNF-dependent manner
Reactive nitrogen species (RNS) are an additional TNF-mediated cell-intrinsic immune
response. TNF in conjunction with IFNγ have been shown to induce RNS, and this
induction has been shown to play a role in the clearance of C. burnetii (Howe et al.,
2010). TNF alone, however, has never been implicated in RNS-mediated restriction of C.
burnetii. Here, we measured induction of iNOS, the protein that synthesizes RNS
through its substrate L-arginine. We found C. burnetii does induce expression of Inos
mRNA via qRT-PCR and this expression is partially dependent on endogenouslyproduced TNF (Figure 3.3A). We further tested if C. burnetii induced formation of a
functional NOS2 protein by measuring levels of RNS in the supernatant. C. burnetii
infection did induce RNS and that induction was partially dependent on endogenous TNF
(Figure 3.3B). Interestingly, exogenous TNF alone was sufficient to induce high levels of
Inos transcript, but was not sufficient to induce dimerization and form a functional iNOS
protein to generate measurable levels of NO2-, indicating that additional stimuli are
necessary for assembly or functional iNOS proteins. These data demonstrate that RNS
is generated by C. burnetii in a TNF-dependent manner, offering one potential
mechanism by which TNF restricts C. burnetii in B6 macrophages.

Coxiella burnetii phase II infection induces ROS, which is a potential mechanism
of bacterial restriction in B6 macrophages
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ROS is another cell-intrinsic control mechanism that can be induced by TNF. Some
studies show C. burnetii does not induce an oxidative burst, while other studies have
demonstrated that ROS is produced in response to C. burnetii infection (Akporiaye et al.,
1990; Brennan et al., 2004; Howe et al., 2002). To determine if C. burnetii can induce
ROS in C57BL/6 macrophages, we infected BMDMs and measured whole cell ROS at
16 hours post-infection by flow cytometry using the reagent H2DCFDA, which is
nonfluorescent but is converted to a green-fluorescent form when oxidation by the
activity of ROS occurs within the cell. We found that C. burnetii does induce measurable
ROS production (Figure 3.4A). To test if ROS was able to inhibit C. burnetii growth, we
measured growth in gp91phox-/- macrophages and found significantly increased growth
in the absence of this component of NADPH oxidase (Figure 3.4B). These data provide
preliminary evidence for an additional TNF-mediated mechanism by which B6 BMDMs
restrict C. burnetii replication.

Coxiella burnetii phase II infection induces expression of Guanylate Binding
Proteins, but they do not play major role in control of bacterial replication
Guanylate binding proteins (GBPs) are a class of interferon-inducible GTPases with a
variety of functions and have been implicated in the control of intracellular pathogens. It
is known that in conjunction with IFNγ, TNF can induce robust expression of all 11
murine GBPs (Olszewski et al., 2006; Vestal and Jeyaratnam, 2011; Yamamoto et al.,
2012); however, the role of TNF alone as an inducer of GBP expression remains poorly
understood. Moreover, a possible role for GBPs in the context of C. burnetii infection has
not been assessed. Here, we tested the induction of two murine GBPs, mGBP-1 and
mGBP-2, which have been shown to exhibit antimicrobial properties via delivery of anti-
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microbial products to autolysosomes. We found that the mRNAs encoding mGBP-1 and
mGBP-2 are induced in B6 BMDMs by TNF alone (Figure 3.5A-B). Furthermore, we
found that C. burnetii infection induces transcription of these GBPs in a dose-dependent
manner (Figures 3.5A and 3.5B). To test if these or other GBPs played a role in C.
burnetii clearance, we measured bacterial replication in GBPChrom3-/- BMDMs (Yamamoto
et al., 2012), which are deficient in mouse GBPs 1, 2, 3, 5, and 7. We did not observe
any difference in bacterial replication in GBP-deficient macrophages (Figure 3.5C), ruling
out these five GBPs as mediators of C. burnetii restriction.

Discussion
Previously we found a major role for the cell surface immune sensors TLR2 and TLR4
as mediators to restrict C. burnetii replication in B6 BMDMs. We also observed induction
of pro-inflammatory cytokines to be dependent on TLR2 and TLR4, and rely on both
Myd88 and Trif adaptor proteins. Since TNF has a known role as a mediator of cellintrinsic immunity against other bacterial pathogens, we hypothesized that TNF induces
multiple cell-intrinsic pathways to restrict C. burnetii replication. In this study, we found
that TNF has a major role in the restriction of C. burnetii. We further investigated three
potential mechanisms of TNF-mediated control: (1) cell death; (2) reactive nitrogen
(RNS) and reactive oxygen (ROS) species; and (3) guanylate-binding proteins (GBPs),
and preliminarily found a role for ROS in controlling C. burnetii replication.
TNF is a pleotropic cytokine that induces a wide array of cell-extrinsic and cellintrinsic proinflammatory responses (Grell, 1995; Wajant et al., 2003). Since TNF is a
major player in inflammation and underlies the pathogenesis of many autoimmune
diseases, researchers have developed a host of anti-TNF therapies (Taylor, 2001). The
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widespread use of these therapies has revealed their use leads to higher susceptibility to
a variety of interacellular pathogens, including M. tubercuolosis and L. pneumophila
(Jinno et al., 2009; Wagner et al., 2002). In our study we sought to elucidate the cellintrinsic mechanism by which TNF inhibits C. burnetii replication in an effort to better
understand how this broad-acting cytokine restricts intracellular bacterial infection.
We first wanted to determine if C. burnetii infection induces these pathways. If
induced, we then wanted to determine if this induction was dependent on TNF and if the
pathway played a role in restricting of bacterial replication. We found that C. burnetii
does induce RNS, ROS, mGBP-1, and mGBP-2 in B6 macrophages, but does not
induce cell death. We then investigated if TNF induces measurable cell death in B6
macrophages. TNF can induce both non-inflammatory extrinsic apoptosis and
inflammatory necrosis (Schulze-Osthoff et al., 1998; Vandenabeele et al., 2010). Both of
these cell death pathways are thought to control intracellular pathogens by eliminating
their replicative niche. Programmed necrosis also has the potential to alert neighboring
immune cells by releasing DAMPs, which stimulate TLRs and cytosolic sensors
(Pasparakis and Vandenabeele, 2015). In the context of C. burnetii infection, whether
cell death is induced or whether it is restricts bacterial infection is unclear. A previous
study demonstrated that C. burnetii inhibits extrinsic apoptosis. In this study, THP-1 cells
were infected for 48 hours and then treated with TNF and cyclohexamide to artificially
induce caspase-8-mediated apoptosis (Voth et al., 2007). They found reduced PARP
cleavage in infected cells compared to uninfected cells. Another study in THP-1 cells
found that cell death does occur in the first 24 hours of C. burnetii infection. This cell
death was caspase-3-independent and TNF-dependent (Zhang et al., 2012). This latter
study suggests that TNF mediated-cell death may be a mechanism of control, whereas
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the earlier study suggests C. burnetii has evolved strategies to evade these control
mechanisms. Here, we determined whether B6 macrophages undergo cell death during
C. burnetii infection. We measured cell death via both the LDH release assay, which
broadly measures general cell death at the population level, and the TUNEL assay,
which is primarily used to detect apoptotic cell death at the single cell level. In both
assays we found no measurable cell death at 24 hours post infection. Since TUNEL
does not stain well for cells undergoing programmed necrosis (Nonaka et al., 2003),
these data do not completely rule out necroptosis as an early mechanism of restriction.
Further studies using propidium iodide staining, which stains both apoptotic and
necroptotic cells or growth curves in Rip3-/- macrophages are necessary to rule out
programmed necrosis as a mechanism of C. burnetii control (Nonaka et al., 2003;
Vandenabeele et al., 2010). Given the LDH bulk assay showed no measurable death, it
is unlikely that necroptosis is robustly induced, if at all.
Our data rule out TNF-mediated apoptosis as a major mechanism of bacterial control
since we observed that death is not robustly induced during C. burnetii infection. A
previous study indicated that artificially induced TNF-mediated extrinsic apoptosis is
inhibited by C. burnetii in human THP-1 cells (Voth et al., 2007), but no direct link to
bacterial effectors was made. Complete inhibition by the T4SS alone is unlikely given
that we see no measurable cell death and we would expect that bacterial effector-driven
inhibition of cell death would not be one hundred percent complete. A more likely reason
is that, unlike Yersinia spp. or Mycobacterium avium, C. burnetii does not induce
extrinsic apoptosis or alternatively, C. burnetii induces an anti-apoptotic signaling
pathway (Fratazzi et al., 1997; Ruckdeschel et al., 1997). Future studies with the T4SSdeficient strain and the exogenous induction of TNF-mediated apoptosis would
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determine if C. burnetii is actively inhibiting this pathway. To conclusively determine
whether this pathway plays a role in the restriction of C. burnetii replication in B6
macrophages, C. burnetii replication could be assessed in Rip3-/-Casp8-/- BMDMs, which
are unable to undergo either extrinsic apoptosis or necroptosis (Pasparakis and
Vandenabeele, 2015).
We also examined ROS and RNS as possible effector mechanisms of TNF-mediated
control of C. burnetii infection in B6 macrophages. ROS and RNS have previously been
shown to be induced by C. burnetii infection in some studies and not induced in others
(Akporiaye et al., 1990; Brennan et al., 2004; Dellacasagrande et al., 2000; Zamboni and
Rabinovitch, 2003). In the presence of exogenous TNF and IFNγ, ROS and RNS were
implicated in the restriction of C. burnetii replication (Zamboni and Rabinovitch, 2003).
However, it has also been shown that C. burnetii secretes an acid phosphatase, which
may play a role in resistance to ROS (Hill and Samuel, 2011). Whether endogenously
produced TNF induces production of ROS and RNS in C57BL/6 macrophages during C.
burnetii infection has not been shown. Moreover, whether RNS and ROS mediate
restriction of C. burnetii in macrophages in the absence of exogenously added
recombinant cytokines has not been extensively studied.
We found Nos2 mRNA and the iNOS byproduct NO2- were induced in B6
macrophages in response to C. burnetii infection, and we observed a significant
reduction in the induction of both Nos2 and RNS in Tnf-/- macrophages. These findings
indicate that C. burnetii does induce a functional iNOS protein that is partially dependent
on the production of endogenous TNF. Tnf-/- macrophages still produced a low level of
iNOS and NO2-, which suggests that another pathway, potentially TLR signaling itself,
can lead to the production of RNS during C. burnetii infection. To determine if iNOS
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plays a role in restriction of C. burnetii, measuring bacterial growth in iNOS-/- BMDMs or
growth in the presence of iNOS inhibitors, such as S-methylisothiourea sulfate and LN(6)-(1-iminoethyl)-lysine (L-NIL) are necessary.
We also demonstrated C. burnetii infection results in production of measurable levels
of whole cell ROS by B6 macrophages. Furthermore, our preliminary results indicate that
gp91phox, a component of NADPH oxidase, plays a role in restricting C. burnetii growth
in B6 macrophages. These data indicate that ROS is induced during infection and
mediate a role in growth restriction, but do not show that this ROS is the direct product of
TNF signaling. Since ROS can be induced by a variety of stimuli and pathways, future
studies should analyze ROS production in Tnf-/- BMDMs to determine if induction is
dependent on this cytokine or via another mechanism.
Interferon-inducible guanylate-binding proteins (GBPs) have recently been implicated
in the cell-intrinsic control of a variety of pathogens and have been shown to be induced
by TNF (Pilla et al., 2014; Vestal and Jeyaratnam, 2011; Yamamoto et al., 2012). Their
role in host control of C. burnetii infection has not been assessed. Moreover, it is not
known whether TNF alone, in the absence of interferon, is sufficient to induce expression
of many mGBPs. Here we demonstrated that either TNF alone or C. burnetii infection
are sufficient to induce expression of the mRNAs encoding mGBP-1 and mGBP-2, which
have been shown to exhibit antiviral and antiparasitic responses by delivery of
antimicrobial cargo to the autophagosome (Degrandi et al., 2013; Vestal and
Jeyaratnam, 2011). We further tested if mGBP-1,-2,-3,-5, and -7 play a role in growth
restriction using mice missing these GBPs, which are encoded on chromosome 3
(Yamamoto et al., 2012). We found that these five murine GBPs were not required to
restrict C. burnetii replication. Induction of mouse GBPs present on chromosome 5,
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mGBP-6,-8,-9,-10,-11 (mGBP-4 is non-functioning in C57BL/6 macrophages) and
whether these GBPs are localized to the C. burnetii vacuole should also be tested. If C.
burnetii does induce these GBPs, then experiments examining the roles of these GBPs
during C. burnetii infection using siRNA-mediated gene silencing could shed light on
their role in restricting bacterial replication.
In conclusion, we were able to build upon our previous findings that TLR detection of
C. burnetii infection is a major mechanism of control in C57BL/6 macrophages.
Furthermore, we were able to implicate TNF produced as a consequence of TLR
detection as a major player in this restriction. In our analysis of possible TNF-mediated
restriction mechanisms, our preliminary data indicate that the NADPH oxidase plays a
role in the inhibition of C. burnetii replication in C57BL/6 macrophages.
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Figure 3.1 Endogenous TNF restricts intracellular growth of C. burnetii. (A)
C57BL/6 and Tnf-/- BMDMs were infected with WT C. burnetii NMII expressing mCherry
at MOI=100. C. burnetii GEs were determined by qPCR on days 1, 3, 5, and 7 postinfection. Graphs show the fold change in GEs relative to day 1 ± SEM of triplicate wells.
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Representative of three independent experiments. (B) 10ng/mL rTNF or supernatants
from C57BL/6 BMDMs infected with WT C. burnetii NMII for 24 hours were added to WT
C. burnetii-infected Tnf-/- and Tlr2-/- BMDMs on days 1 and 5 post-infection. C. burnetii
GEs were measured by qPCR and the fold increase in GEs on day 7 post-infection was
determined relative to the GEs on Day 1. Graphs show the fold change in GEs relative to
day 1 ± SEM of triplicate wells. Representative of two independent experiments. (C) B6
or Tnf-/- BMDMs were infected with mCherry-expressing WT C. burnetii or 10ng/mL rTNF
was added to mCherry-expressing WT C. burnetii-infected Tnf-/- BMDMs on days 1 and 5
post-infection. On day 7 post-infection, cells were fixed, stained with DAPI, and imaged
by fluorescence microscopy. The number of mCherry-expressing C. burnetii-containing
vacuoles was determined and calculated as a percentage of total cell number. Graphs
show mean percentage of cells containing C. burnetii vacuoles ± SEM of triplicate
coverslips. At least 300 cells were counted per coverslip. (D) Representative images
(40x) of mCherry-expressing C. burnetii-containing vacuoles in infected BMDMs treated
as in (C). Scale bars represent 25µM. Representative of two independent experiments.
(E) 10ng/mL rTNF or supernatants from B6 BMDMs infected with WT C. burnetii NMII for
24 hours were added to WT C. burnetii-infected Tlr2-/- BMDMs on days 1 and 5 postinfection. C. burnetii GEs were measured by qPCR and the fold increase in GEs on day
7 post-infection was determined relative to the GEs on Day 1. Graphs show the fold
change in GEs relative to day 1 ± SEM of triplicate wells. Representative of two
independent experiments. *p<0.05, **p<0.01, ***p<0.001, ns=no significance.
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Figure 3.2 C. burnetii does not induce apoptosis in B6 macrophages. (A) and (B)
C57BL/6 BMDMs were infected with WT C. burnetii NMII expressing mCherry at
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fluorescence microscopy. The number of TUNEL positive cells was determined and
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TUNEL positive cells ± SEM of triplicate coverslips. At least 300 cells were counted per
coverslip. (B) Representative images (20x) of TUNEL positive cells positive cells.
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Experiment 1: iNOS expression in B6 vs TNF
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Figure 3.3 C. burnetii infection does induce iNOS mRNA and NO2- in a TNF
dependent manner. C57BL/6 and Tnf-/- BMDMs were mock-infected, treated with E. coli
LPS, 10 ng/mL mouse recombinant TNF, or infected with WT C. burnetii NMII at MOI=
50 or 100. (A) 16 hours post infection, fold-induction of Nos2 mRNAs were measured via
qRT-PCR. Graphs show the mean ± SEM of triplicate wells in a 48 well plate.
Representative of two independent experiments. (B) NO2- was measured in the
supernatants 24 hours post infection. Graphs show the mean ± SEM of triplicate wells in
a 96 well plate. Representative of two independent experiments. *p<0.05, **p<0.01.
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16 hours. Whole cell ROS was measured by flow cytometry. Representative of two
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***p<0.001.

	
  

99

	
  
GBP-1

C8
Fold Change (GE)!

6

300

8

4 6

200
80

r4

r4

-/-

-/-

GBPChr3-/-! Tnf-/-!
Tl

r2

-/-

Tl

Tl

M

Data 3

B6!

-/-

50! 100!
WT Coxiella!

r2

k!
10
rm ng
TN /m
F! L

0

Tl

40

B6

2 4
2
0
0

0

f-/
Tn

BP
G

B6

-/-

10

50
W
T

W
T

60
10

ng
/m
L

80

rm
TN
F

M
oc
k

100

10

5

oc
M

10
rm ng
TN /m
F! L

0
k!

mGBP-2 fold-induction!

B

Day 1
Day71
Day
Day 7

10

400

oc

mGBP-1 fold-induction!

A

Figure 5 TLR24
Data 2

50! 100!
WT Coxiella!

10
0

W
T

50

W
T

rm
TN
F

ng
/m
L

M

oc

k

Figure 3.5 C. burnetii infection induces expression of mGBP-1 and mGBP-2, but
10

GBPs 1, 2, 3, 5, and 7 do not play a role in restricting C. burnetii replication. (A)
and (B) C57BL/6 BMDMs were mock-infected, 10 ng/mL recombinant mouse TNF, or
infected with WT C. burnetii NMII at MOI= 50 or 100. 16 hours post infection, foldinduction of mGBP-1 and mGBP-2 mRNAs were measured via qRT-PCR. Graphs show
the mean ± SEM of triplicate wells in a 48 well plate. Representative of two independent
experiments. (C) C57BL/6, GBPchrm3-/- and Tnf-/- were infected with WT C. burnetii NMII
expressing mCherry at MOI=100. C. burnetii GEs were determined by qPCR on days 1,
3, 5, and 7 post-infection. Graphs show the fold change in GEs relative to day 1 ± SEM
of triplicate wells. Graphs show the mean ± SEM of triplicate wells.
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In the studies described here, we sought to determine the innate immune response
mounted by macrophages against C. burnetii burnetii, a poorly understood intracellular
bacterium. The C. burnetii field has made great advances over the years. The advent of
an axenic growth media and improved methods for genetic manipulation has given the
scientific community new tools to better understand its pathogenesis. While the field has
made considerable progress in understanding the cell biology of C. burnetii’s intracellular
niche, the innate immune response to C. burnetii is poorly understood. This is in part due
to wide variation in cell lines, animal models, and bacterial strains employed by different
groups.
Our first goal was to establish a standardized system in C57BL/6 primary bone
marrow-derived macrophages. This system has been used to study a variety of
pathogens and due to the large number of available mice with select innate immune
deficiencies, allowed us to cast a wide net in the innate immune pathways we analyzed.
Furthermore, in the context of the C. burnetii Nine Mile phase II strain, this system offers
a unique opportunity to study cell-intrinsic mechanism of bacterial control as C57BL/6
macrophages are naturally able to restrict C. burnetii NMII infection.
With this infection system, in our first aim we sought to answer two questions: [1]
which innate immune responses are activated in vitro; and [2] what role does Type IV
secretion system-mediated translocation of bacterial products play in triggering these
innate immune responses. We hypothesized that since C. burnetii is able to survive
inside cells over a long period of time and delays neutrophil recruitment in the lung
(Elliott et al., 2013; van Schaik et al., 2013), it evolved strategies to evade innate
immune detection, potentially through the injection of T4SS effector proteins. Our survey
of three classical innate immune pathways allowed us to implicate TLR-mediated TNF
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production as a major player in the cell-intrinsic control of C. burnetii in C57BL/6
macrophages.

TLR detection is more critical than cytosolic detection for the induction of proinflammatory cytokines and the cell-intrinsic control of Coxiella
To address our first aim, we assessed C. burnetii’s ability to activate various innate
immune pathways in C57BL/6 BMDMs. To further test our hypothesis that C. burnetii
has evolved strategies to subvert innate immune detection we investigated the role of its
T4SS in activating these pathways. In particular, we examined cell surface and cytosolic
immune detection and induction of pro-inflammatory cytokines, the activation of the
inflammasome, and the induction of Type I interferon response. We wanted to both
determine C. burnetii’s ability to activate these pathways and test whether they mediated
cell-intrinsic control of bacterial replication (Zamboni, 2004). Furthermore, to determine
the role of the T4SS in mediating these responses, we utilized an isogenic NMII strain
containing a transposon insertion in the gene icmL (Carey et al., 2011).
In these studies, we built upon past work that showed an important role for TLR2 in
mediating production of pro-inflammatory cytokines and an inconclusive role for TLR4
(Barry et al., 2012; Shannon et al., 2005; Zamboni et al., 2004). We confirmed previous
findings that TLR2 plays a major role in the production of pro-inflammatory cytokines
TNF and IL-6, but also found a role for TLR4 in the induction of these cytokines. Upon
further analysis of the downstream adaptors MyD88 and Trif, we found a role for both
MyD88 and Trif in both the production of TNF and IL-6 and the inhibition of C. burnetii
replication. Since Trif is classically thought to signal only through TLR4 and TLR3 (Akira,
2003), with TLR3 largely associated with recognition of viral infection, this further
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suggests TLR4 responds to C. burnetii infection. We wanted to next determine whether
C. burnetii’s LPS was the ligand responsible for TLR4-dependent responses. Past
studies have shown that purified C. burnetii LPS is not stimulatory for TLR4 and instead
acts as a TLR4 antagonist (Zamboni et al., 2004). We confirmed this was the case in our
system. TLR4 can also recognize host danger-associated molecular patterns (DAMPs)
that are released upon infection such as HMGB-1 (Pasparakis and Vandenabeele,
2015), but these are unlikely since we observe no measurable cell death 24 hours post
infection. One possibility is that TLR4 recognition of C. burnetii LPS requires
simultaneous detection of other bacterial PAMPs by other TLRs.
Since the T4SS is required for C. burnetii growth within host cells (Beare et al., 2011),
it is possible that restrictive C57BL/6 macrophages are somehow not permissive for
translocation of T4SS substrates, and thus cytosolic immune sensors would not be
triggered during C. burnetii infection in this cell type. We confirmed via a single cell
assay that the C. burnetii T4SS does inject effectors into C57BL/6 macrophages,
allowing us to further investigate whether cytosolic immune detection occurs. To
examine this, we first compared the ability of WT NMII and icmL::Tn NMII, lacking a
functional T4SS, to induce proinflammatory cytokines. The L. pneumophila T4SS has
been shown to trigger an enhanced cytokine response, presumably due to its
translocation of multiple bacterial ligands that are detected by cytosolic sensors that
promote cytokine expression. We interestingly found no increase in TNF or IL-6
production by B6 macrophages infected with WT bacteria compared to the icmL::Tn
mutant, and our data suggest that there is a slight decrease in TNF and IL-6 production
in response to WT bacteria. This suggests that C. burnetii either does not secrete
immunostimulatory ligands or that it inhibits cytokine production via one or more T4SS
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effectors. Future studies will determine if C. burnetii T4SS effectors are actively blocking
TNF and IL-6 production. Since C. burnetii has undergone genome reduction over its
evolutionary history, it is also possible that it has altered or eliminated genes encoding
immunostimulatory ligands.
To further test whether there is cytosolic immune detection of C. burnetii, we
investigated C. burnetii’s ability to activate the inflammasome. To test this, we used a
variety of readouts for inflammasome activation that have been employed to study the
inflammasome in the context of other bacterial pathogens, such as L. pneumophila
(Casson and Shin, 2013). We surprisingly found no activation of the inflammasome
following C. burnetii infection of B6 macrophages, even in cells that had been primed
with LPS to ensure that all the necessary inflammasome components were highly
upregulated. This phenomenon could again be the result of C. burnetii not encoding
inflammasome-activating ligands or actively inhibiting inflammasome activation via T4SS
effectors, as seen with Yersinia species, which utilize the T3SS effectors YopK and
YopM to inhibit caspase-1 activation (Brodsky et al., 2010; LaRock and Cookson, 2012).
Future studies that examine whether C. burnetii can inhibit inflammasome activation
downstream of external stimuli, similar to those used to determine that C. burnetii inhibits
intrinisic apoptosis, would offer further insight into C. burnetii’s subversion of the
inflammasome.
Type I interferon (IFN) was the final arm of the innate immune response we studied.
Type I IFNs are thought to primarily play a role in the immune response to viruses and
have the potential to be induced by immune sensors both at the cell surface and within
the cytosol (Müller et al., 1994). Recently, they been shown to play a role in some
bacterial infections (Lippmann et al., 2011; Monroe et al., 2010). Studies have shown
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type I IFNs can restrict Legionella replication (Coers et al., 2007; Schiavoni et al., 2004),
while other studies have shown that they can promote bacterial infection, as is the case
for M. tuberculosis (Manzanillo et al., 2012). Whether type I IFNs play a role in restricting
C. burnetii infection has not been studied. Despite a role for Trif, which induces type I
IFN production downstream of IRF-3 phosphorylation (Akira, 2003), in both cytokine
production and bacterial restriction, we did not observe robust induction of Type I
interferon, nor did we observe a role for type I IFNs in the restriction of C. burnetii
replication in B6 macrophages.
In sum, we determined that TLR detection plays a dominant role in the production of
proinflammatory cytokines during C. burnetii infection. Although we found that the T4SS
is functional and translocates bacterial products into B6 macrophages, our data rule out
cytosolic immune activation of pro-inflammatory cytokines and the inflammasome as
major players mediating the restriction of C. burnetii growth in B6 macrophages. We
further ruled out the type I IFN response as being induced or playing a role in cellintrinsic restriction during C. burnetii infection. It again is possible that C. burnetii inhibits
type I IFN induction through the activity of its T4SS effectors or does not possess or
expose immunostimulatory ligands that robustly activate the sensors leading to type I
IFN induction. However, since Trif plays an important role in TNF and IL-6 induction
during C. burnetii infection, we would have anticipated that Trif signaling would have also
led to type I IFN induction. In future studies, it would be of interest to determine if IRF3 is
phosphorylated. If IRF3 is activated, then it is possible that C. burnetii may target the
transcription or translation of type I IFNs.
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TNF is a mechanism by which B6 macrophages inhibit Coxiella burnetii
replication.
We expanded upon our initial studies, which implicated TLRs as the major sensors
responsible for production of cytokines during C. burnetii infection and cell-intrinsic
control of bacterial replication. We hypothesized that TLR signaling induces a soluble
factor that then activates an antimicrobial response. We found TNF, a pleiotropic
cytokine that activates many cell-intrinsic and cell-extrinsic immune pathways, plays a
major role in C. burnetii restriction. TNF has been implicated in the restriction of a variety
of pathogens through the induction of cell death pathways, the activation of an
antimicrobial response within infected cells (RNS, ROS, antimicrobial peptides, etc.), the
induction of autophagy, alterations in iron acquisition, and the induction of guanylate
binding proteins (Bekker et al., 2001; Johnson and Wessling-Resnick, 2012; Pasparakis
and Vandenabeele, 2015; Yamamoto et al., 2012; Yuk et al., 2012).
We narrowed our studies towards examining three possible mechanisms: apoptotic
and necroptotic cell death, production of RNS and ROS, and induction of guanylate
binding proteins. Autophagy is a possible mechanism of control; however, there is strong
evidence that C. burnetii actively engages the autophagy pathway to promote its
intracellular growth. Whether there is a role for host-driven modulation of iron levels in
restricting C. burnetii infection is unclear, although a study suggested that C. burnetii
actually replicated better within macrophage lines treated with an iron chelator compared
to iron-replate macrophages (Briggs et al., 2008). It is possible that TNF-mediated
alterations in phagocytic iron levels could still play a role in limiting C. burnetii replication.
We found C. burnetii does not induce cell death at measurable levels in C57BL/6
macrophages using both population-based and single cell-based assays, suggesting
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that apoptosis and necroptosis are likely not major TNF-mediated control mechanisms in
vitro. One possible caveat is that we did not use a single cell assay to detect
necroptosis, so it is still possible that this form of cell death is occurring, and it is possible
that necroptosis could mediate restriction of C. burnetii by occurring at an earlier time
point in a small number of infected cells. However, since we observed the formation of
large C. burnetii-containing vacuoles in a relatively large percentage of cells (~10-20%)
in infected permissive macrophages lacking TLR2 or TNF, that would suggest that death
of a small number of infected cells would not be sufficient to limit C. burnetii infection in
our model. Since C. burnetii has been shown to inhibit intrinsic apoptosis through its
T4SS, it is also possible that it uses bacterial effectors to inhibit extrinsic apoptosis and
necroptosis. Studies where these pathways are artificially induced in C. burnetii-infected
cells could aid in determining whether C. burnetii actively inhibits these cell death
pathways and shed light on how C. burnetii is able to grow inside macrophages while
inducing minimal cell death.
We did find that there was induction of both RNS and ROS in response to C. burnetii
infection, and we further found RNS induction to be dependent on TNF. Future studies
will determine whether ROS production is TNF-dependent. Our preliminary data also
indicate that the NADPH oxidase, a major generator of ROS, plays a role in the
restriction of C. burnetii replication in B6 macrophages, and future studies will determine
whether RNS play a role in restricting C. burnetii replication in B6 macrophages. Studies
with S. Typhimurium, which has a relatively short replication time within the host cell,
showed ROS to be a major mediator of bacterial growth restriction (Mantena et al.,
2008), while studies with M. tubercuolosis, which has a longer replication time within the
host cell, showed RNS to be a major restriction factor (Davis et al., 2007). Since C.
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burnetii has a long replication time, it would be interesting to know if RNS plays a role in
restriction at a later time point than ROS. These two pathways could target C. burnetii
replication at different stages of its prolonged life cycle inside the cell.
We found that treatment of macrophages with TNF alone or C. burnetii infection of
macrophages is capable of inducing two GBPs, GBP-1 and GBP-2, but did not find any
evidence of a role for these or other GBPs in mediating growth restriction, as we did not
observe increased C. burnetii replication when five of the eleven murine GBPs (GBP-1, 2, -3, -5, and -7) were absent. Further studies are necessary to implicate or definitively
rule out GBPs as a potential effector mechanism underlying TNF-mediated bacterial
restriction. Furthermore, since the C. burnetii vacuole can expand to occupy the majority
of the cell cytosol and recruits membranes from a variety of sources, it would be
interesting to know if any of the GBPs localize to the C. burnetii-containing vacuole.

Future Directions
Innate immune detection of Coxiella burnetii by cell surface and cytosolic sensors
Our findings open doors for many future studies aimed at examining the innate
immune response to C. burnetii and its ability to evade innate immune detection. In
continuing our first aim, short-term future directions should: define the exact signaling
cascades activated by MyD88 and Trif signaling, determine whether TLR4 (or another
TLR) is responsible for Trif-mediated signaling, and determine whether there is T4SSmediated inhibition of these pathways. Long-term future directions should include:
analysis of the activation of these innate immune pathways in human cell lines and
primary human cells and in vivo studies in mice.
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Further defining which specific downstream signaling pathways are activated (NF-κB,
MAPKs, IRFs) would offer a more complete picture of how TLRs and adaptors induce
signaling cascades that lead to the expression of pro-inflammatory cytokines and other
immune proteins. Since pro-inflammatory cytokine production can occur downstream of
both NF-κB and MAPK activation, a complete picture of C. burnetii’s activation of these
pathways would be useful in determining its ability to manipulate or evade some of these
innate immune responses.
We have not yet directly demonstrated that TLR4 mediates Trif signaling during C.
burnetii infection. Furthermore, we found that purified C. burnetii LPS does not stimulate
cytokine production in B6 macrophages, making it unclear how C. burnetii infection is
triggering TLR4 signaling. Studies in cell lines ectopically expressing TLR4 or both TLR2
and TLR4 could shed light on determining whether TLR4 detects and signals through Trif
in the context of the whole bacterium and whether TLR4 is sufficient to mediate
responses to C. burnetii. It is also possible that TLR4-mediated detection of C. burnetii
infection may somehow require an initial signal emanating from TLR2 detection. Thus,
these studies should also include cell lines expressing both TLR2 and TLR4 to test this
latter possibility.
Many intracellular bacteria utilize their secretion systems to translocate effector
proteins that directly inhibit the activation of innate immune responses (Brodsky and
Medzhitov, 2009). Since C. burnetii injects over 100 effector proteins, it is likely that
some of these effectors target innate immune signaling pathways. Further studies could
provide insight into whether there is T4SS-mediated inhibition of immune signaling.
Comparing immune responses following artificial induction of immune pathways in
infected cells versus uninfected cells would be one way to determine whether the T4SS
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mediates immune inhibition, analogous to past studies showing that artificially induced
intrinisic apoptosis is inhibited in a T4SS-dependent manner. For example, studies
comparing responses to WT vs icmL::Tn C. burnetii NMII strains following induction of
inflammasome activation with exogenous addition of ATP or induction of type I interferon
with poly(I:C) would be useful. If cells infected with WT C. burnetii display less innate
immune activation, then this would suggest that the T4SS translocates effectors that
dampen immune signaling.
In the long-term, studies should examine innate immune responses to C. burnetii
infection in human and murine macrophages. Humans and mice have evolved many
divergent innate immune pathways. While our studies in mouse macrophages show the
inflammasome is not activated and type I interferons are not induced during C. burnetii
infection, it is possible that human immune sensors are able to respond to C. burnetii
infection. One study with primary human alveolar macrophages showed that C. burnetii
infection induces the release of IL-1β, but did not implicate inflammasome activation in
this system. Further studies in THP-1 cells and human primary macrophages would
provide important insight into innate immune detection and control of C. burnetii.
Our studies only examined activation of innate immune pathways in macrophages. It
is possible that different innate immune pathways are activated in other cells that would
be expected to come into contact with C. burnetii in the lungs of an infected host, such
as neutrophils, dendritic cells, and airway epithelial cells. Future studies examining the
innate immune responses of these different cell types to C. burnetii would provide
important insight into this question. Furthermore, future studies in mice using an
intranasal model of infection could determine if these pathways are activated in systemic
infection.
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TNF as an Inhibitor of Coxiella burnetii Intracellular Replication
How TNF signaling restricts the intracellular replication of C. burnetii within host cells is
unclear. To provide additional insight into the underlying mechanism, short-term future
directions, building upon our initial findings, should: further determine whether RNS and
ROS are responsible for the ability of TNF to mediate restriction and further analyze
whether the mGBPs play a role in restricting C. burnetii infection,. Long term future
directions should include examining the role of TNF in controlling C. burnetii growth and
dissemination during in vivo infection.
TNF signaling can lead to cell death in other systems, but our data suggested that
cell death was not robustly triggered during C. burnetii infection of macrophages.
Examining C. burnetii replication in WT B6 macrophages compared to macrophages
deficient in RIP3, which is required for necroptosis, or both RIP3 and caspase-8, which
eliminates both extrinsic apoptosis and necroptosis, would provide important insight into
whether cell death mediates TNF-dependent restriction of C. burnetii replication. Our
data indicate that iNOS and the production of RNS are induced during C. burnetii
infection in a TNF-dependent manner. Future experiments using RNS inhibitors or iNOSdeficient macrophages will aid in determining whether iNOS and RNS are involved in
restricting C. burnetii replication. While we found that whole cell ROS was induced in
response to C. burnetii infection, and our preliminary data suggest that the NADPH
oxidase plays a role in restriction of C. burnetii, studies of ROS production in Tnf-/macrophages are necessary to link ROS-mediated restriction to TNF. It is also possible
that TNF signaling somehow inhibits efficient T4SS translocation as a means to restrict
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C. burnetii replication. Experiments that measure the magnitude of injection in WT and
TNF-deficient macrophages using the BlaM translocation assay could help answer this.
Future studies should also examine whether GBPs are possible mediators of C.
burnetii restriction within B6 macrophages, as our preliminary data indicate that at least
two GBPs, mGBP-1 and mGBP-2, are transcriptionally induced during C. burnetii
infection. GBPs have been implicated in restricting the intracellular replication of a
variety of vacuolar pathogens, and further analysis of their expression and localization
patterns and performing a targeted siRNA screen of the mGBPs could offer insight into
their role during C. burnetii infection. While they have classically been thought to play a
role in restriction of pathogens, it is also possible that their induction and recruitment to
the vacuole may benefit C. burnetii and aid in its replication. C. burnetii is thought to
engage with the autophagy pathway to promote its intracellular replication so it would be
of interest to know if GBPs also fulfill a similar role.
It would also be of interest to determine which cells in the infected population are
producing TNF. L. pneumophila and S. flexneri employ effector proteins that inhibit the
production of pro-inflammatory cytokines by targeting host translational elongation
factors and p38 and ERK MAPK signaling, respectively (Reiterer et al., 2011; Rolando
and Buchrieser, 2014). In the case of L. pneumophila, it was recently shown using single
cell assays that bystander cells are the primary producers of TNF and other cytokines
(Copenhaver et al., 2015). Our studies thus far have relied largely on population-based
assays, but single cell-based assays examining whether infected or uninfected cells
produce cytokines would provide insight. Using the CCF4-AM/BlaM system in
conjunction with mCherry-expressing C. burnetii would help divide the cells into
uninfected, infected but uninjected, and T4SS-injected cells. A significant reduction in
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cytokine-positive cells in the T4SS-injected population compared to uninjected cells
would suggest that C. burnetii T4SS activity actively blocks production of
proinflammatory cytokines.
Our studies focused solely on cell-intrinsic pathways of TNF restriction within
macrophages during in vitro infection with the Nine Mile II strain, which is attenuated for
virulence. It would also be of interest to determine the role for TNF in control of systemic
infection with virulent C. burnetii strains. Intranasal infection of WT and TNF-deficient
mice and measurement of bacterial burdens would offer a broader view of TNF as a
control mechanism during in vivo infection. Since granulomas are thought to be
important in the restriction of C. burnetii and may be linked to the formation of chronic
infection, assays for granuloma formation in WT and TNF-deficient infected animals
would be of great interest.
Finally, it is important to determine whether C. burnetii T4SS effectors participate in
innate immune subversion. C. burnetii encodes over 100 effector proteins, many of
which contain eukaryotic protein domains and unique localization patterns (Carey et al.,
2011). Our discovery of various immune pathways that are not robustly activated during
C. burnetii infection, such as inflammasome activation or the induction of type I IFNs,
would offer possible phenotypes amenable to screening for T4SS effectors that inhibit
these innate immune responses using gain-of-function or loss-of-function genetic
approaches. Furthermore, advances in the field have allowed for the generation of
transposon mutant libraries of effector proteins and it is now possible to test the roles of
these effectors in inhibiting innate immune pathways in a similar fashion to the types of
studies that have been performed in more genetically malleable bacteria.
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Concluding Remarks
Innate immune recognition is a crucial first step in detecting and preventing microbial
infection. Eukaryotic organisms have evolved specialized immune sensors that
recognize a broad array of pathogen-associated molecular patterns (PAMPs). Detection
of pathogens via these sensors activates cell-intrinsic and -extrinsic immune pathways to
clear invaders. Many pathogens have evolved strategies to evade detection from these
sensors in order to overcome innate immune barriers to infection. These evasion
techniques can involve alterations in their PAMPs to become less immunostimulatory or
the production of virulence factors that actively block key components of innate immune
pathways. Intracellular bacteria pose a unique set of challenges for host organisms.
They are shielded from circulating immune cells and molecules and also have evolved
mechanisms to hijack host cells in order to form their replicative niche and evade
intracellular detection. Much remains to be understood about how the innate immune
system detects and controls the intracellular replication of this unique class of
pathogens.
Coxiella burnetii is an intracellular bacterium that lives and grows in the lysosome, the
harshest environment found within a cell. This bacterium can replicate in cells
unchecked for days and can establish acute and chronic infections in humans. Unlike
other bacteria, C. burnetii does not seem to induce robust innate immune activation. In
these studies, we sought to define the innate immune pathways that C. burnetii does and
does not activate in mouse macrophages, and understand the roles of these pathways in
restricting C. burnetii infection. To address these questions, we chose to use restrictive
B6 macrophages, which control C. burnetii replication, as a model for understanding the
host factors involved in successful restriction of C. burnetii replication. We found that C.
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burnetii infection does not robustly activate cytosolic immune sensors, the
inflammasome, or the Type I interferon response. Instead, we found induction of proinflammatory cytokines and intracellular restriction of C. burnetii replication to be largely
dependent on TLR signaling. The lack of a robust cytosolic immune response is
remarkable because C. burnetii is capable of translocating bacterial effectors into the
host cell cytosol of B6 macrophages. How it is able to accomplish effector translocation
into host cells, while evading the slew of cytosolic immune sensors present within these
cells, remains unknown, but it is likely C. burnetii has many strategies to overcome
innate immune detection, potentially through its T4SS effectors.
Our findings also implicated endogenously produced TNF as a major mediator of cellintrinsic immunity against C. burnetii within B6 macrophages. TNF is a broad-acting
cytokine with a wide variety of downstream immune responses. We sought to determine
the mechanism of TNF-mediated cell-intrinsic control by testing the role of several
putative effector pathways known to be TNF-regulated in other systems. Our findings
indicate that cell death likely does not play a major role in TNF-mediated restriction.
Furthermore, our preliminary data suggest that several of the murine guanylate binding
proteins are not required for TNF-mediated restriction. In addition, we further found that
C. burnetii induces ROS and RNS, and our preliminary data suggest that the NADPH
oxidase plays a role in cell-intrinsic control. Future studies are necessary to determine
whether these pathways mediate the TNF-dependent restriction of C. burnetii infection,
but our model system using C57BL/6-background macrophages deficient in select
immune genes will allow us to test the role of these pathways in controlling C. burnetii
infection.
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Together, our studies suggest that C. burnetii does not robustly activate many innate
immune pathways, but also offer new insight into possible mechanisms by which host
cells are able to overcome C. burnetii’s subversion and restrict intracellular replication.
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Figure 4.1. Proposed Mechanism of TLR-mediated control of C. burnetii
replication in C57BL/6 macrophages. Restriction of C. burnetii replication in C57BL/6
macrophages is dependent on TLR-mediated induction and secretion of TNF. TLR2 and
TLR4 recognize C. burnetii and signal through both adaptors MyD88 and Trif to induce
the production of TNF. TNF then binds to infected cells to induce the production of
reactive oxygen species (ROS) and reactive nitrogen species (RNS) which inhibit
intracellular replication of C. burnetii. Restriction of replication in C56BL/6 is independent
of cytosolic innate immune sensors.
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